CSF analysis in the diagnosis of viral encephalitis and meningitis

Clinical Neurovirology

Volumn , Issue , 2003, Pages 43-107

  Cinque, Paola ^a   Linde, Annika ^b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67649369018     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (396)

1. Rubin, S.J.: Detection of viruses in spinal fluid. Am. J. Med. 1983, 75, 124–128.
2. Fredricks, D.N.; Relman, D.A. Application of polymerase chain reaction to the diagnosis of infectious diseases. Clin. Infect. Dis. 1999, 29, 475–486; quiz 487–478.
3. Puchhammer-Stockl, E.; Popow-Kraupp, T.; Heinz, F.X.; Mandl, C.W.; Kunz, C. Establishment of PCR for the early diagnosis of herpes simplex encephalitis. J. Med. Virol. 1990, 32, 77–82.
4. Rotbart, H.A.: Diagnosis of enteroviral meningitis with the polymerase chain reaction. J. Pediatr. 1990, 117, 85–89.
5. Kaneko, K.; Onodera, O.; Miyatake, T.; Tsuji, S. Rapid diagnosis of tuberculous meningitis by polymerase chain reaction (PCR). Neurology. 1990, 40, 1617–1618.
6. Darnell, R.B. The polymerase chain reaction: application to nervous system disease. Ann. Neurol. 1993, 34, 513–523.
7. Tyler, K.L.: Polymerase chain reaction and the diagnosis of viral central nervous system diseases. Ann. Neurol. 1994, 36, 809–811.
8. Weber, T.; Frye, S.; Bodemer, M.; Otto, M.; Luke, W. Clinical implications of nucleic acid amplification methods for the diagnosis of viral infections of the nervous system. J. Neurovirol. 1996, 2, 175–190.
9. Cinque, P.; Cleator, G.M.; Weber, T.; Monteyne, P.; Sindic, C.J.; van Loon, A.M. The role of laboratory investigation in the diagnosis and management of patients with suspected herpes simplex encephalitis: a consensus report. The EU Concerted Action on Virus Meningitis and Encephalitis. J. Neurol. Neurosurg. Psychiatry. 1996, 61, 339–345.
10. Fishman, R.A. Cerebrospinal Fluid in Diseases of the Central Nervous System, 2nd ed.; W.B. Saunders: Philadelphia, 1992.
11. Greenlee, J.E.; Carroll, C. Cerebrospinal fluid in CNS infections. In Infections of the Central Nervous System; Scheld, W.M., Whitley, R.J., Durack, D.T., Eds.; Lippincott-Raven: Philadelphia, 1997, 899–922.
12. Painter, P.C.; Cope, J.Y.; Smith, J.L. Appendix. Reference intervals. Tietz Textbook of Chemical Chemistry; Burtis, C.A., Ashwood, E.R., Eds.; W.B. Saunders: Philadelphia, 1994, 2175–2218.
13. Quincke, H.I.: Die Lumbalpunction des Hydrocephalus. Berl. Klin. Wochenschr. 1891, 929–965.
14. Marton, K.I.; Gean, A.D. The spinal tap: a new look at an old test. Ann. Intern. Med. 1986, 104, 840–848.
15. Health and Public Policy Committee, American College of Physicians. The diagnostic spinal tap. Ann. Intern. Med. 1986, 104, 880–886.
16. Kuntz, K.M.; Kokmen, E.; Stevens, J.C.; Miller, P.; Offord, K.P.; Ho, M.M. Post-lumbar puncture headaches: experience in 501 consecutive procedures. Neurology. 1992, 42, 1884–1887.
17. Brocker, R.J. Technique to avoid spinal tap headache. JAMA. 1958, 68, 261–263.
18. Vilming, S.T.; Schrader, H.; Monstad, I. Post-lumbar-puncture headache: the significance of body posture. A controlled study of 300 patients. Cephalalgia. 1988, 78, 75–78.
19. Spriggs, D.A.; Burn, D.J.; French, J.; Cartlidge, N.E.; Bates, D. Is bed rest useful after diagnostic lumbar puncture?. Postgrad. Med. J. 1992, 68, 581–583.
20. Greene, H.M. Lumbar puncture and the prevention of post puncture headache. JAMA. 1926, 86, 391–392.
21. Ready, L.B.; Cuplin, S.; Haschke, R.H.; Nessly, M. Spinal needle determinants of rate of transdural fluid leak. Anesth Analg. 1989, 69, 457–460.
22. Halpern, S.; Preston, R.: Postdural puncture headache and spinal needle design. Metaanalyses. Anesthesiology. 1994, 81, 1376–1383.
23. Mihic, D.N.: Postspinal headaches, needle surfaces and longitudinal orientation of the dural fibers. Results of a survey. Reg. Anaesth. 1986, 9, 54–56.
24. Braune, H.J.; Huffmann, G.A. A prospective double-blind clinical trial, comparing the sharp Quincke needle (22G) with an “atraumatic” needle (22G) in the induction of post-lumbar puncture headache. Acta. Neurol. Scand. 1992, 86, 50–54.
25. Muller, B.; Adelt, K.; Reichmann, H.; Toyka, K. Atraumatic needle reduces the incidence of post-lumbar puncture syndrome. J. Neurol. 1994, 241, 376–380.
26. Thomas, S.R.; Jamieson, D.R.; Muir, K.W. Randomised controlled trial of atraumatic versus standard needles for diagnostic lumbar puncture. Br. Med. J. 2000, 321, 986–990.
27. Strupp, M.; Brandt, T.; Muller, A. Incidence of post-lumbar puncture syndrome reduced by reinserting the stylet: a randomized prospective study of 600 patients. J. Neurol. 1998, 245, 589–592.
28. Tourtellotte, W.W.; Henderson, W.G.; Tucker, R.P.; Gilland, O.; Walker, J.E.; Kokman, E. A randomized, double-blind clinical trial comparing the 22 versus 26 gauge needle in the production of the post-lumbar puncture syndrome in normal individuals. Headache. 1972, 12, 73–78.
29. Carson, D.; Serpell, M. Choosing the best needle for diagnostic lumbar puncture. Neurology. 1996, 47, 33–37.
30. Strachan, A.; Lumbar puncture and headache, J.: Train. Aspirating cerebrospinal fluid speeds up procedure. Br. Med. J. 1998, 316, 1018–1019.
31. Serpell, M.G.; Rawal, N. Headaches after diagnostic dural punctures. Br. Med. J. 2000, 321, 973–974.
32. Adler, M.D.; Comi, A.E.; Walker, A.R. Acute hemorrhagic complication of diagnostic lumbar puncture. Pediatr. Emerg. Care. 2001, 17, 184–188.
33. Howard, S.C.; Gajjar, A.; Ribeiro, R.C.; Rivera, G.K.; Rubnitz, J.E.; Sandlund, J.T.; Harrison, P.L.; de Armendi, A.; Dahl, G.V.; Pui, C.H. Safety of lumbar puncture for children with acute lymphoblastic leukemia and thrombocytopenia. JAMA. 2000, 284, 2222–2224.
34. Duffy, G.P.: Lumbar puncture in the presence of raised intracranial pressure. Br. Med. J. 1969, 1, 407–409.
35. Spanos, A.; Harrell, F.E. Jr.; Differential diagnosis of acute meningitis, D.T. Durack. An analysis of the predictive value of initial observations. JAMA. 1989, 262, 2700–2707.
36. Portnoy, J.M.; Olson, L.C. Normal cerebrospinal fluid values in children: another look. Pediatrics. 1985, 75, 484–487.
37. Adair, C.V.; Gauld, R.L.; Smadel, J.E. Aseptic meningitis, a disease of diverse etiology: clinical and etiological studies on 854 cases. Ann. Intern. Med. 1953, 39, 675–704.
38. Singh, N.; Anderegg, K.A.; Yu, V.L.: Significance of hypoglycorrhachia in patients with AIDS and cytomegalovirus meningoencephalitis. Clin. Infect. Dis. 1993, 17, 283–284.
39. Silverman, L.M.; Christenseon, R.H. Amino acids and protein. In Tietz Textbook of Chemical Chemistry; Burtis, C.A., Ashwood, E.R., Eds.; W.B. Saunders: Philadelphia, 1994, 625–725.
40. Bailey, E.M.; Domenico, P.; Cunha, B.A. Bacterial or viral meningitis? Measuring lactate in CSF can help you know quickly. Postgrad. Med. 1990, 88, 217–219, 223.
41. Hsich, G.; Kenney, K.; Gibbs, C.J.; Lee, K.H.; Harrington, M.G. The 14–3–3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N. Engl. J. Med. 1996, 335, 924–930.
42. Lebon, P.; Boutin, B.; Dulac, O.; Ponsot, G.; Arthuis, M. Interferon gamma in acute and subacute encephalitis. Br. Med. J. (Clin. Res. Ed.). 1988, 296, 9–11.
43. Brew, B.J.; Bhalla, R.B.; Fleisher, M.; Paul, M.; Khan, A.; Schwartz, M.K.; Price, R.W. Cerebrospinal fluid beta 2 microglobulin in patients infected with human immunodeficiency virus. Neurology. 1989, 39, 830–834.
44. Fuchs, D.; Chiodi, F.; Albert, J.; Asjo, B.; Hagberg, L.; Hausen, A.; Norkrans, G.; Reibnegger, G.; Werner, E.R.; Wachter, H. Neopterin concentrations in cerebrospinal fluid and serum of individuals infected with HIV-1. AIDS. 1989, 3, 285–288.
45. Heyes, M.P.; Rubinow, D.; Lane, C.; Markey, S.P. Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndrome. Ann. Neurol. 1989, 26, 275–277.
46. Cinque, P.; Vago, L.; Mengozzi, M.; Torri, V.; Ceresa, D.; Vicenzi, E.; Transidico, P.; Vagani, A.; Sozzani, S.; Mantovani, A.; Lazzarin, A.; Poli, G. Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication. AIDS. 1998, 12, 1327–1332.
47. Conant, K.; Garzino-Demo, A.; Nath, A.; McArthur, J.C.; Halliday, W.; Power, C.; Gallo, R.C.; Major, E.O.: Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc. Natl. Acad. Sci. USA. 1998, 95, 3117–3121.
48. Link, H.; III, G. Tibbling.: Principles of albumin and IgG analyses in neurological disorders. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis. Scand. J. Clin. Lab. Invest. 1977, 37, 397–401.
49. Tourtellotte, W.W.; Ma, B.I. Multiple sclerosis: the blood-brain-barrier and the measurement of de novo central nervous system IgG synthesis. Neurology. 1978, 28, 76–83.
50. Reiber, H. The discrimination between different blood-CSF barrier dysfunctions and inflammatory reactions of the CNS by a recent evaluation graph for the protein profile of cerebrospinal fluid. J. Neurol. 1980, 224, 89–99.
51. Andersson, M.; Alvarez-Cermeno, J.; Bernardi, G.; Cogato, I.; Fredman, P.; Frederiksen, J.; Fredrikson, S.; Gallo, P.; Grimaldi, L.M.; Gronning, M. Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J. Neurol. Neurosurg. Psychiatry. 1994, 57, 897–902.
52. Koskiniemi, M.; Vaheri, A.; Taskinen, E. Cerebrospinal fluid alterations in herpes simplex virus encephalitis. Rev. Infect. Dis. 1984, 6, 608–618.
53. Mengel, M. The use of the cytocentrifuge in the diagnosis of meningitis. Am. J. Clin. Pathol. 1985, 84, 212–216.
54. Varki, A.P.; Value of second lumbar puncture in confirming a diagnosis of aseptic meningitis, P.Puthuran. A prospective study. Arch. Neurol. 1979, 36, 581–582.
55. Dagan, R.; Jenista, J.A.; Menegus, M.A.: Association of clinical presentation, laboratory findings, and virus serotypes with the presence of meningitis in hospitalized infants with enterovirus infection. J. Pediatr. 1988, 113, 975–978.
56. Henquell, C.; Chambon, M.; Bailly, J.L.; Alcaraz, S.; De Champs, C.; Archimbaud, C.; Labbe, A.; Charbonne, F.; Peigue-Lafeuille, H. Prospective analysis of 61 cases of enteroviral meningitis: interest of systematic genome detection in cerebrospinal fluid irrespective of cytologic examination results. J. Clin. Virol. 2001, 21, 29–35.
57. Ramers, C.; Billman, G.; Hartin, M.; Ho, S.; Sawyer, M.H. Impact of a diagnostic cerebrospinal fluid enterovirus polymerase chain reaction test on patient management. JAMA. 2000, 283, 2680–2685.
58. Levitt, L.P.; Rich, T.A.; Kinde, S.W.; Lewis, A.L.; Gates, E.H.; Bond, J.O. Central nervous system mumps. A review of 64 cases. Neurology. 1970, 20, 829–834.
59. Bergstrom, T.; Vahlne, A.; Alestig, K.; Jeansson, S.; Forsgren, M.; Lycke, E.: Primary and recurrent herpes simplex virus type 2-induced meningitis. J. Infect. Dis. 1990, 162, 322–330.
60. Aurelius, E.; Forsgren, M.; Skoldenberg, B.; Strannegard, O. Persistent intrathecal immune activation in patients with herpes simplex encephalitis. J. Infect. Dis. 1993, 168, 1248–1252.
61. Appleman, M.E.; Marshall, D.W.; Brey, R.L.; Houk, R.W.; Beatty, D.C.; Winn, R.E.; Melcher, G.P.; Wise, M.G.; Sumaya, C.V.; Boswell, R.N. Cerebrospinal fluid abnormalities in patients without AIDS who are seropositive for the human immunodeficiency virus. J. Infect. Dis. 1988, 158, 193–199.
62. Hollander, H.: Cerebrospinal fluid normalities and abnormalities in individuals infected with human immunodeficiency virus. J. Infect. Dis. 1988, 158, 855–858.
63. de Gans, J.; Portegies, P.; Tiessens, G.; Troost, D.; Danner, S.A.; Lange, J.M. Therapy for cytomegalovirus polyradiculomyelitis in patients with AIDS: treatment with ganciclovir. AIDS. 1990, 4, 421–425.
64. Pantoni, L.; Inzitari, D.; Colao, M.G.; De Mayo, E.; Marini, P.; Mazzota, F. Cytomegalovirus encephalitis in a non-immunocompromised patient: CSF diagnosis by in situ hybridization cells. Acta. Neurol. Scand. 1991, 84, 56–58.
65. Musiani, M.; Zerbini, M.; Venturoli, S.; Gentilomi, G.; Borghi, V.; Pietrosemoli, P.; Pecorari, M.; La Placa, M. Rapid diagnosis of cytomegalovirus encephalitis in patients with AIDS using in situ hybridisation. J. Clin. Pathol. 1994, 47, 886–891.
66. Revello, M.G.; Percivalle, E.; Sarasini, A.; Baldanti, F.; Furione, M.; Gerna, G. Diagnosis of human cytomegalovirus infection of the nervous system by pp65 detection in polymorphonuclear leukocytes of cerebrospinal fluid from AIDS patients. J. Infect. Dis. 1994, 170, 1275–1279.
67. Steele, R.W.; Keeney, R.E.; Bradsher, R.W.; Moses, E.B.; Soloff, B.L. Treatment of varicellazoster meningoencephalitis with acyclovir—demonstration of virus in cerebrospinal fluid by electron microscopy. Am. J. Clin. Pathol. 1983, 80, 57–60.
68. Johnson, G.; Nelson, S.; Petric, M.; Tellier, R.: Comprehensive PCR-based assay for detection and species identification of human herpesviruses. J. Clin. Microbiol. 2000, 38, 3274–3279.
69. Andersson, J.; Ehrnst, A.; Larsson, P.H.; Hedlund, K.O.; Norrby, E.; Nybom, R.; Forsgren, M.; Olding-Stenquist, E.; Persson, B. Visualization of defective measles virus particles in cerebrospinal fluid in subacute sclerosing panencephalitis. J. Infect. Dis. 1987, 156, 928–933.
70. Sonnerborg, A.; Nybom, R.; Britton, S.; Ehrnst, A.; Forsgren, M.; Larsson, P.H.; Strannegard, O.; Andersson, J. Detection of cell-free human immunodeficiency virus in cerebrospinal fluid by using immune scanning electron microscopy. J. Infect. Dis. 1989, 159, 1037–1041.
71. Chua, K.B.; Goh, K.J.; Wong, K.T.; Kamarulzaman, A.; Tan, P.S.; Ksiazek, T.G.; Zaki, S.R.; Paul, G.; Lam, S.K.; Tan, C.T. Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia. Lancet. 1999, 354, 1257–1259.
72. Paton, N.I.; Leo, Y.S.; Zaki, S.R.; Auchus, A.P.; Lee, K.E.; Ling, A.E.; Chew, S.K.; Ang, B.; Rollin, P.E.; Umapathi, T.; Sng, I.; Lee, C.C.; Lim, E.; Ksiazek, T.G. Outbreak of Nipahvirus infection among abattoir workers in Singapore. Lancet. 1999, 354, 1253–1256.
73. Chow, V.T.; Tambyah, P.A.; Yeo, W.M.; Phoon, M.C.; Howe, J. Diagnosis of Nipah virus encephalitis by electron microscopy of cerebrospinal fluid. J. Clin. Virol. 2000, 19, 143–147.
74. Chua, K.B.; Bellini, W.J.; Rota, P.A.; Harcourt, B.H.; Tamin, A.; Lam, S.K.; Ksiazek, T.G.; Rollin, P.E.; Zaki, S.R.; Shieh, W.; Goldsmith, C.S.; Gubler, D.J.; Roehrig, J.T.; Eaton, B.; Gould, A.R.; Olson, J.; Field, H.; Daniels, P.; Ling, A.E.; Peters, C.J.; Anderson, L.J.; Mahy, B.W. Nipah virus: a recently emergent deadly paramyxovirus. Science. 2000, 288, 1432–1435.
75. Chonmaitree, T.; Menegus, M.A.; Powell, K.R. The clinical relevance of “CSF viral culture”. A two-year experience with aseptic meningitis in Rochester, NY. JAMA. 1982, 247, 1843–1847.
76. Calisher, C.H.: Medically important arboviruses of the United States and Canada. Clin. Microbiol. Rev. 1994, 7, 89–116.
77. McIntosh, K. Diagnostic virology. In Fields Virology; Fields, B.N., Knipe, P.M., Howley, P.M., Eds.; Lippincott-Raven: Philadelphia, 1996, 401–430.
78. Storch, A.G. Methodological overview. In Essentials of Diagnostic Virology; Storch, G.A., Ed.; Churchill Livingstone: New York, 2000, 1–23.
79. Nahmias, A.J.; Whitley, R.J.; Visintine, A.N.; Takei, Y.; Alford, C.A. Jr. Herpes simplex virus encephalitis: laboratory evaluations and their diagnostic significance. J. Infect. Dis. 1982, 145, 829–836.
80. Whitley, R.J.; Arvin, A.M. Herpes simplex virus infections. In Infectious Diseases of the Fetus and Newborn Infant; Remington, J.S., Klein, J.O., Eds.; W.B. Saunders: Philadelphia, 1995, 354–376.
81. Dix, R.D.; McCarthy, M.; Berger, J.R. Diagnostic value for culture of cerebrospinal fluid from HIV-1-infected individuals for opportunistic viruses: a prospective study. AIDS. 1994, 8, 307–312.
82. Andiman, W.A.; White-Greenwald, M.; Tinghitella, T.: Zoster encephalitis. Isolation of virus and measurement of varicella-zoster-specific antibodies in cerebrospinal fluid. Am. J. Med. 1982, 73, 769–772.
83. Peterson, L.R.; Ferguson, R.M. Fatal central nervous system infection with varicella-zoster virus in renal transplant recipients. Transplantation. 1984, 37, 366–368.
84. Snoeck, R.; Gerard, M.; Sadzot-Delvaux, C.; Andrei, G.; Balzarini, J.; Reymen, D.; Ahadi, N.; De Bruyn, J.M.; Piette, J.; Rentier, B. Meningoradiculoneuritis due to acyclovir-resistant varicella zoster virus in an acquired immune deficiency syndrome patient. J. Med. Virol. 1994, 42, 338–347.
85. Echevarria, J.M.; Casas, I.; Martinez-Martin, P. Infections of the nervous system caused by varicella-zoster virus: a review. Intervirology. 1997, 40, 72–84.
86. So, Y.T.; Olney, R.K. Acute lumbosacral polyradiculopathy in acquired immunodeficiency syndrome: experience in 23 patients. Ann. Neurol. 1994, 35, 53–58.
87. Gozlan, J.; el Amrani, M.; Baudrimont, M.; Costagliola, D.; Salord, J.M.; Duvivier, C.; Picard, O.; Meyohas, M.C.; Jacomet, C.; Schneider-Fauveau, V. A prospective evaluation of clinical criteria and polymerase chain reaction assay of cerebrospinal fluid for the diagnosis of cytomegalovirus- related neurological diseases during AIDS. AIDS. 1995, 9, 253–260.
88. Cinque, P.; Cleator, G.M.; Weber, T.; Monteyne, P.; Sindic, C.; Gerna, G.; van Loon, A.M.; Klapper, P.E.: Diagnosis and clinical management of neurological disorders caused by cytomegalovirus in AIDS patients. European Union Concerted Action on Virus Meningitis and Encephalitis. J. Neurovirol. 1998, 4, 120–132.
89. Halsted, C.C.; Chang, R.S. Infectious mononucleosis and encephalitis: recovery of EB virus from spinal fluid. Pediatrics. 1979, 64, 257–258.
90. Schiff, J.A.; Schaefer, J.A.; Robinson, J.E. Epstein-Barr virus in cerebrospinal fluid during infectious mononucleosis encephalitis. Yale. J. Biol. Med. 1982, 55, 59–63.
91. Kelsey, D.S. Adenovirus meningoencephalitis. Pediatrics. 1978, 61, 291–293.
92. Cardosa, M.J.; Krishnan, S.; Tio, P.H.; Perera, D.; Wong, S.C. Isolation of subgenus B adenovirus during a fatal outbreak of enterovirus 71-associated hand, foot, and mouth disease in Sibu, Sarawak. Lancet. 1999, 354, 987–991.
93. Yerly, S.; Gervaix, A.; Simonet, V.; Caflisch, M.; Perrin, L.; Wunderli, W.: Rapid and sensitive detection of enteroviruses in specimens from patients with aseptic meningitis. J. Clin. Microbiol. 1996, 34, 199–201.
94. Atkinson, P.J.; Sharland, M.; Maguire, H. Predominant enteroviral serotypes causing meningitis. Arch. Dis. Child. 1998, 78, 373–374.
95. Nairn, C.; Clements, G.B. A study of enterovirus isolations in Glasgow from 1977 to 1997. J. Med. Virol. 1999, 58, 304–312.
96. Rotbart, H.A. Enteroviruses. In Manual of Clinical Microbiology; Murray, P.R., Baron, E.J., Pfaller, M.A., Tenover, F.C., Yolken, R.H., Eds.; Am. Soc. Microbiol: Washington, DC, 1999, 990–998.
97. Squadrini, F.; Taparelli, F.; De Rienzo, B.; Giovannini, G.; Pagani, C. Rubella virus isolation from cerebrospinal fluid in postnatal rubella encephalitis. Br. Med. J. 1977, 2, 1329–1330.
98. Abe, T.; Nukada, T.; Hatanaka, H.; Tajima, M.; Hiraiwa, M.; Ushijima, H. Myoclonus in a case of suspected progressive rubella panencephalitis. Arch. Neurol. 1983, 40, 98–100.
99. Dwyer, D.E.; Hueston, L.; Field, P.R.; Cunningham, A.L.; North, K. Acute encephalitis complicating rubella virus infection. Pediatr. Infect. Dis. J. 1992, 11, 238–240.
100. Frey, T.K. Neurological aspects of rubella virus infection. Intervirology. 1997, 40, 167–175.
101. McCullers, J.A.; Facchini, S.; Chesney, P.J.; Webster, R.G. Influenza B virus encephalitis. Clin. Infect. Dis. 1999, 28, 898–900.
102. Hakoda, S.; Nakatani, T. A pregnant woman with influenza A encephalopathy in whom influenza A/Hong Kong virus (H3) was isolated from cerebrospinal fluid. Arch. Intern. Med. 1045, 2000, 160, 1041.
103. Wolontis, S.; Bjorvatn, B. Mumps meningoencephalitis in Stockholm. V. Virus isolations from samples of cerebrospinal fluid and urine—a comparison between some cell systems and typing techniques. Scand. J. Infect. Dis. 1974, 6, 117–123.
104. Donald, P.R.; Burger, P.J.; Becker, W.B. Mumps meningo-encephalitis. S. Afr. Med. J. 1987, 71, 283–285.
105. Poggio, G.P.; Rodriguez, C.; Cisterna, D.; Freire, M.C.; Cello, J. Nested PCR for rapid detection of mumps virus in cerebrospinal fluid from patients with neurological diseases. J. Clin. Microbiol. 2000, 38, 274–278.
106. Wairagkar, N.S.; Gandhi, B.V.; Katrak, S.M.; Shaikh, N.J.; Parikh, P.R.; Wadia, N.H.; Gadkari, D.A. Acute renal failure with neurological involvement in adults associated with measles virus isolation. Lancet. 1999, 354, 992–995.
107. Arisoy, E.S.; Demmler, G.J.; Thakar, S.; Doerr, C. Meningitis due to parainfluenza virus type 3: report of two cases and review. Clin. Infect. Dis. 1993, 17, 995–997.
108. Chua, K.B.; Lam, S.K.; Tan, C.T.; Hooi, P.S.; Goh, K.J.; Chew, N.K.; Tan, K.S.; Kamarulzaman, A.; Wong, K.T. High mortality in Nipah encephalitis is associated with presence of virus in cerebrospinal fluid. Ann. Neurol. 2000, 48, 802–805.
109. Peters, C.J.; Buchmeier, M.; Rollin, P.E.; Ksiazek, T.G. Arenaviruses. In Fields Virology; Fields, B.N., Knipe, P.M., Howley, P.M., Eds.; Lippincott-Raven: Philadelphia, 1996, 1521–1551.
110. Nogueira, Y.L. Morphometric analysis of McCoy cells inoculated with cerebrospinal fluid from patients with rabies. Mem. Inst. Oswaldo Cruz. 1998, 4, 509–514.
111. Spector, S.A.; Hsia, K.; Pratt, D.; Lathey, J.; McCutchan, J.A.; Alcaraz, J.E.; Atkinson, J.H.; Gulevich, S.; Wallace, M.; Virologic markers of human immunodeficiency virus type 1 in cerebrospinal fluid, I.Grant. The HIV Neurobehavioral Research Center Group. J. Infect. Dis. 1993, 168, 68–74.
112. Brew, B.J.; Paul, M.O.; Nakajima, G.; Khan, A.; Gallardo, H.; Price, R.W. Cerebrospinal fluid HIV-1 p24 antigen and culture: sensitivity and specificity for AIDS-dementia complex. J. Neurol. Neurosurg. Psychiatry. 1994, 57, 784–789.
113. Pratt, R.D.; Nichols, S.; McKinney, N.; Kwok, S.; Dankner, W.M.; Spector, S.A. Virologic markers of human immunodeficiency virus type 1 in cerebrospinal fluid of infected children. J. Infect. Dis. 1996, 174, 288–293.
114. Andersson, L.M.; Svennerholm, B.; Hagberg, L.; Gisslen, M. Higher HIV-1 RNA cutoff level required in cerebrospinal fluid than in blood to predict positive HIV-1 isolation. J. Med. Virol. 2000, 62, 9–13.
115. McKendall, R.R.; Oas, J.; Lairmore, M.D. HTLV-I-associated myelopathy endemic in Texasborn residents and isolation of virus from CSF cells. Neurology. 1991, 41, 831–836.
116. Sotomayor, E.A.; Josephson, S.L.: Isolation of eastern equine encephalitis virus in A549 and MRC-5 cell cultures. Clin. Infect. Dis. 1999, 29, 193–195.
117. Mendoza-Montero, J.; Gamez-Rueda, M.I.; Navarro-Mari, J.M.; de la Rosa-Fraile, M.; Oyonarte-Gomez, S. Infections due to sandfly fever virus serotype Toscana in Spain. Clin. Infect. Dis. 1998, 27, 434–436.
118. Valassina, M.; Meacci, F.; Valensin, P.E.; Cusi, M.G. Detection of neurotropic viruses circulating in Tuscany: the incisive role of Toscana virus. J. Med. Virol. 2000, 60, 86–90.
119. Tsai, T.F. Arboviruses. In Manual of Clinical Microbiology; Murray, P.R., Baron, E.J., Pfaller, M.A., Tenover, F.C., Yolken, R.H., Eds.; Am. Soc. Microbiol: Washington, DC, 1999, 1107–1124.
120. van Regenmortel, M.H.V.; Fauquet, C.M.; Bishop, D.H.L.; Carstens, E.B.; Estes, M.K.; Lemon, S.M.; Maniloff, J.; Mayo, M.A.; McGeoch, D.J.; Pringle, C.R.; Wickner, R.B. Virus Taxonomy. The Classification and Nomenclature of Viruses. The Seventh Report of the International Committee on Taxonomy of Viruses; Academic Press: San Diego, 2000.
121. Muir, P.; van Loon, A.M. Enterovirus infections of the central nervous system. Intervirology. 1997, 40, 153–166.
122. Muir, P.; Kammerer, U.; Korn, K.; Mulders, M.N.; Poyry, T.; Weissbrich, B.; Kandolf, R.; Cleator, G.M.; Molecular typing of enteroviruses: current status and future requirements, A.M.van Loon. The European Union Concerted Action on Virus Meningitis and Encephalitis. Clin. Microbiol. Rev. 1998, 11, 202–227.
123. Singer, J.I.; Maur, P.R.; Riley, J.P.; Smith, P.B. Management of central nervous system infections during an epidemic of enteroviral aseptic meningitis. J. Pediatr. 1980, 96, 559–563.
124. Lindeman, J.; Muller, W.K.; Versteeg, J.; Bots, G.T.; Peters, A.C. Rapid diagnosis of meningoencephalitis, encephalitis. Immunofluorescent examination of fresh and in vitro cultured cerebrospinal fluid cells. Neurology. 1974, 24, 143–148.
125. Taber, L.H.; Brasier, F.; Couch, R.B.; Greenberg, S.B.; Jones, D.; Knight, V. Diagnosis of herpes simplex virus infection by immunofluorescence. J. Clin. Microbiol. 1976, 3, 309–312.
126. Maltseva, N.; Manovich, Z.; Seletskaya, T.; Kaptsova, T.; Nikulina, V. Rapid diagnosis of viral neuroinfections by immunofluorescent and immunoperoxidase technics. J. Neurol. 1979, 220, 125–130.
127. Coleman, R.M.; Bailey, P.D.; Whitley, R.J.; Keyserling, H.; Nahmias, A.J. ELISA for the detection of herpes simplex virus antigens in the cerebrospinal fluid of patients with encephalitis. J. Virol. Methods. 1983, 7, 117–125.
128. Bos, C.A.; Olding-Stenkvist, E.; Wilterdink, J.B.; Scheffer, A.J. Detection of viral antigens in cerebrospinal fluid of patients with herpes simplex virus encephalitis. J. Med. Virol. 1987, 21, 169–178.
129. Lakeman, F.D.; Koga, J.; Whitley, R.J. Detection of antigen to herpes simplex virus in cerebrospinal fluid from patients with herpes simplex encephalitis. J. Infect. Dis. 1987, 155, 1172–1178.
130. Royal, W.; Selnes, O.A.; Concha, M.; Nance-Sproson, T.E.; McArthur, J.C. Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) p24 antigen levels in HIV-1-related dementia. Ann. Neurol. 1994, 36, 32–39.
131. de Gans, J.; Lange, J.M.; Derix, M.M.; de Wolf, F.; Eeftinck Schattenkerk, J.K.; Danner, S.A.; Ongerboer de Visser, B.W.; Cload, P.; Goudsmit, J. Decline of HIV antigen levels in cerebrospinal fluid during treatment with low-dose zidovudine. AIDS. 1988, 2, 37–40.
132. Flood, J.; Drew, W.L.; Miner, R.; Jekic-McMullen, D.; Shen, L.P.; Kolberg, J.; Garvey, J.; Follansbee, S.; Poscher, M. Diagnosis of cytomegalovirus (CMV) polyradiculopathy and documentation of in vivo anti-CMV activity in cerebrospinal fluid by using branched DNA signal amplification and antigen assays. J. Infect. Dis. 1997, 176, 348–352.
133. Mathur, A.; Kumar, R.; Sharma, S.; Kulshreshtha, R.; Kumar, A.; Chaturvedi, U.C. Rapid diagnosis of Japanese encephalitis by immunofluorescent examination of cerebrospinal fluid. Indian J. Med. Res. 1990, 91, 1–4.
134. Gajanana, A.; Samuel, P.P.; Thenmozhi, V.; Rajendran, R. An appraisal of some recent diagnostic assays for Japanese encephalitis. Southeast Asian J. Trop. Med. Public Health. 1996, 27, 673–679.
135. Yolken, R.H.; Torsch, V. Enzyme-linked immunosorbent assay for the detection and identification of coxsackie B antigen in tissue cultures and clinical specimens. J. Med. Virol. 1980, 6, 45–52.
136. Yolken, R.H.; Torsch, V.M.: Enzyme-linked immunosorbent assay for detection and identification of coxsackieviruses A. Infect. Immun. 1981, 31, 742–750.
137. Boyd, J.F.; Vince-Ribaric, V. The examination of cerebrospinal fluid cells by fluorescent antibody staining to detect mumps antigen. Scand. J. Infect. Dis. 1973, 5, 7–15.
138. Dayan, A.D.; Stokes, M.I. Immunofluorescent detection of measles-virus antigens in cerebrospinal- fluid cells in subacute sclerosing panencephalitis. Lancet. 1971, 1, 891–892.
139. Tedder, D.G.; Ashley, R.; Tyler, K.L.; Levin, M.J. Herpes simplex virus infection as a cause of benign recurrent lymphocytic meningitis. Ann. Intern. Med. 1994, 121, 334–338.
140. Schlesinger, Y.; Buller, R.S.; Brunstrom, J.E.; Moran, C.J.; Storch, G.A. Expanded spectrum of herpes simplex encephalitis in childhood. J. Pediatr. 1995, 126, 234–241.
141. De Vincenzo, J.P.; Thorne, G. Mild herpes simplex encephalitis diagnosed by polymerase chain reaction: a case report and review. Pediatr. Infect. Dis. J. 1994, 13, 662–664.
142. Domingues, R.B.; Tsanaclis, A.M.; Pannuti, C.S.; Mayo, M.S.; Lakeman, F.D. Evaluation of the range of clinical presentations of herpes simplex encephalitis by using polymerase chain reaction assay of cerebrospinal fluid samples. Clin. Infect. Dis. 1997, 25, 86–91.
143. Fodor, P.A.; Levin, M.J.; Weinberg, A.; Sandberg, E.; Sylman, J.; Tyler, K.L. Atypical herpes simplex virus encephalitis diagnosed by PCR amplification of viral DNA from CSF. Neurology. 1998, 51, 554–559.
144. Arribas, J.R.; Storch, G.A.; Clifford, D.B.; Tselis, A.C. Cytomegalovirus encephalitis. Ann. Intern. Med. 1996, 125, 577–587.
145. Kondo, K.; Nagafuji, H.; Hata, A.; Tomomori, C.; Yamanishi, K. Association of human herpesvirus 6 infection of the central nervous system with recurrence of febrile convulsions. J. Infect. Dis. 1993, 167, 1197–1200.
146. Suga, S.; Yoshikawa, T.; Asano, Y.; Kozawa, T.; Nakashima, T.; Kobayashi, I.; Yazaki, T.; Yamamoto, H.; Kajita, Y.; Ozaki, T. Clinical and virological analyses of 21 infants with exanthem subitum (roseola infantum) and central nervous system complications. Ann. Neurol. 1993, 33, 597–603.
147. Barah, F.; Vallely, P.J.; Chiswick, M.L.; Cleator, G.M.; Kerr, J.R. Association of human parvovirus B19 infection with acute meningoencephalitis. Lancet. 2001, 358, 729–730.
148. Studahl, M.; Bergstrom, T.; Ekeland-Sjoberg, K.; Ricksten, A. Detection of cytomegalovirus DNA in cerebrospinal fluid in immunocompetent patients as a sign of active infection. J. Med. Virol. 1993, 46, 274–280.
149. Ushijima, H.; Xin, K.Q.; Nishimura, S.; Morikawa, S.; Abe, T. Detection and sequencing of rotavirus VP7 gene from human materials (stools, sera, cerebrospinal fluids, and throat swabs) by reverse transcription and PCR. J. Clin. Microbiol. 1993, 32, 2893–2897.
150. McCullers, J.A.; Lakeman, F.D.; Whitley, R.J. Human herpesvirus 6 is associated with focal encephalitis. Clin. Infect. Dis. 1993, 21, 571–576.
151. Tang, Y.W.; Persing, D.H. Molecular detection and identification of microorganisms. In Manual of Clinical Microbiology; Murray, P.R., Baron, E.J., Pfaller, M.A., Tenover, F.C., Yolken, R.H., Eds.; Am. Soc. Microbiol: Washington, DC, 1999, 215–244.
152. Mullis, K.B.; Faloona, F.A. Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods. Enzymol. 1987, 155, 335–350.
153. Kievits, T.; van Gemen, B.; van Strijp, D.; Schukkink, R.; Dircks, M.; Adriaanse, H.; Malek, L.; Sooknanan, R.; Lens, P. NASBA isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection. J. Virol. Methods. 1991, 35, 273–286.
154. Zhang, F.; Tetali, S.; Wang, X.P.; Kaplan, M.H.; Cromme, F.V.; Ginocchio, C.C. Detection of human cytomegalovirus pp67 late gene transcripts in cerebrospinal fluid of human immunodeficiency virus type 1-infected patients by nucleic acid sequence-based amplification. J. Clin. Microbiol. 2000, 38, 1920–1925.
155. Bestetti, A.; Pierotti, C.; Terreni, M.; Zappa, A.; Vago, L.; Lazzarin, A.; Cinqu, P. Comparison of three nucleic acid amplification assays of cerebrospinal fluid for diagnosis of cytomegalovirus encephalitis. J. Clin. Microbiol. 2001, 39, 1148–1151.
156. McArthur, J.C.; McClernon, D.R.; Cronin, M.F.; Nance-Sproson, T.E.; Saah, A.J.; St Clair, M.; Lanier, E.R. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain. Ann. Neurol. 1997, 42, 689–698.
157. Shepard, R.N.; Schock, J.; Robertson, K.; Shugars, D.C.; Dyer, J.; Vernazza, P.; Hall, C.; Cohen, M.S.; Fiscus, S.A. Quantitation of human immunodeficiency virus type 1 RNA in different biological compartments. J. Clin. Microbiol. 2000, 38, 1414–1418.
158. Lanciotti, R.S.; Kerst, A.J.: Nucleic acid sequence-based amplification assays for rapid detection of West Nile and St. Louis encephalitis viruses. J. Clin. Microbiol. 2001, 39, 4506–4513.
159. Fox, J.D.; Han, S.; Samuelson, A.; Zhang, Y.; Neale, M.L.; Westmoreland, D.: Development and evaluation of nucleic acid sequence based amplification (NASBA) for diagnosis of enterovirus infections using the NucliSens Basic Kit. J. Clin. Virol. 2002, 24, 117–130.
160. Urdea, M.S. Branched DNA signal amplification. Biotechnology (NY). 1994, 12, 926–928.
161. Stingele, K.; Haas, J.; Zimmermann, T.; Stingele, R.; Hubsch-Muller, C.; Freitag, M.; Storch- Hagenlocher, B.; Hartmann, M.; Wildemann, B. Independent HIV replication in paired CSF and blood viral isolates during antiretroviral therapy. Neurology. 2001, 56, 355–361.
162. Casas, I.; Powell, L.; Klapper, P.E.; Cleator, G.M.: New method for the extraction of viral RNA and DNA from cerebrospinal fluid for use in the polymerase chain reaction assay. J. Virol. Methods. 1995, 53, 25–36.
163. Fahle, G.A.; Fischer, S.H.: Comparison of six commercial DNA extraction kits for recovery of cytomegalovirus DNA from spiked human specimens. J. Clin. Microbiol. 2000, 38, 3860–3863.
164. Kimura, H.; Shibata, M.; Kuzushima, K.; Nishikawa, K.; Nishiyama, Y.; Morishima, T.: Detection and direct typing of herpes simplex virus by polymerase chain reaction. Med. Microbiol. Immunol. (Berl). 1990, 179, 177–184.
165. Cassinotti, P.; Mietz, H.; Siegl, G.: Suitability and clinical application of a multiplex nested PCR assay for the diagnosis of herpes simplex virus infections. J. Med. Virol. 1996, 50, 75–81.
166. Cinque, P.; Vago, L.; Marenzi, R.; Giudici, B.; Weber, T.; Corradini, R.; Ceresa, D.; Lazzarin, A.; Linde, A. Herpes simplex virus infections of the central nervous system in human immunodeficiency virus-infected patients: clinical management by polymerase chain reaction assay of cerebrospinal fluid. Clin. Infect. Dis. 1998, 27, 303–309.
167. Tenorio, A.; Echevarria, J.E.; Casas, I.; Echevarria, J.M.; Tabares, E.: Detection and typing of human herpesviruses by multiplex polymerase chain reaction. J. Virol. Methods. 1993, 44, 261–269.
168. Baron, J.M.; Rubben, A.; Grussendorf-Conen, E.I. Evaluation of a new general primer pair for rapid detection and differentiation of HSV-1, HSV-2, and VZV by polymerase chain reaction. J. Med. Virol. 1996, 49, 279–282.
169. Pozo, F.; Tenorio, A.: Detection and typing of lymphotropic herpesviruses by multiplex polymerase chain reaction. J. Virol. Methods. 1999, 79, 9–19.
170. Quereda, C.; Corral, I.; Laguna, F.; Valencia, M.E.; Tenorio, A.; Echeverria, J.E.; Navas, E.; Martin-Davila, P.; Moreno, A.; Moreno, V.; Gonzalez-Lahoz, J.M.; Arribas, J.R.; Guerrero, A. Diagnostic utility of a multiplex herpesvirus PCR assay performed with cerebrospinal fluid from human immunodeficiency virus-infected patients with neurological disorders. J. Clin. Microbiol. 2000, 38, 3061–3067.
171. Read, S.J.; Kurtz, J.B. Laboratory diagnosis of common viral infections of the central nervous system by using a single multiplex PCR screening assay. J. Clin. Microbiol. 1999, 37, 1352–1355.
172. Casas, I.; Pozo, F.; Trallero, G.; Echevarria, J.M.; Tenorio, A. Viral diagnosis of neurological infection by RT multiplex PCR: a search for entero- and herpesviruses in a prospective study. J. Med. Virol. 1999, 57, 145–151.
173. Roberts, T.C.; Storch, G.A.: Multiplex PCR for diagnosis of AIDS-related central nervous system lymphoma and toxoplasmosis. J. Clin. Microbiol. 1997, 35, 268–269.
174. Kuno, G.: Universal diagnostic RT-PCR protocol for arboviruses. J. Virol. Methods. 1998, 72, 27–41.
175. Rozenberg, F.; Lebon, P.: Amplification and characterization of herpesvirus DNA in cerebrospinal fluid from patients with acute encephalitis. J. Clin. Microbiol. 1991, 29, 2412–2417.
176. Minjolle, S.; Michelet, C.; Jusselin, I.; Joannes, M.; Cartier, F.; Colimon, R. Amplification of the six major human herpesviruses from cerebrospinal fluid by a single PCR. J. Clin. Microbiol. 1999, 37, 950–953.
177. Bouquillon, C.; Dewilde, A.; Andreoletti, L.; Lambert, V.; Chieux, V.; Gerard, Y.; Lion, G.; Bocket, L.; Wattre, P.: Simultaneous detection of 6 human herpesviruses in cerebrospinal fluid and aqueous fluid by a single PCR using stair primers. J. Med. Virol. 2000, 62, 349–353.
178. Arthur, R.R.; Dagostin, S.; Shah, K.V. Detection of BK virus and JC virus in urine and brain tissue by the polymerase chain reaction. J. Clin. Microbiol. 1989, 27, 1174–1179.
179. Fedele, C.G.; Ciardi, M.; Delia, S.; Echevarria, J.M.; Tenorio, A. Multiplex polymerase chain reaction for the simultaneous detection and typing of polymavirus JC, BK and SV40 DNA in clinical samples. J. Virol. Methods. 1999, 82, 137–144.
180. Clementi, M.; Menzo, S.; Bagnarelli, P.; Valenza, A.; Paolucci, S.; Sampaolesi, R.; Manzin, A.; Varaldo, P.E. Clinical use of quantitative molecular methods in studying human immunodeficiency virus type 1 infection. Clin. Microbiol. Rev. 1996, 9, 135–147.
181. Hodinka, R.L. The clinical utility of viral quantitation using molecular methods. Clin. Diagn. Virol. 1998, 10, 25–47.
182. Preiser, W.; Elzinger, B.; Brink, N.S. Quantitative molecular virology in patient management. J. Clin. Pathol. 2000, 53, 76–83.
183. Holland, P.M.; Abramson, R.D.; Watson, R.; Gelfand, D.H. Detection of specific polymerase chain reaction product by utilizing the 5′→3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proc. Natl. Acad. Sci. USA. 1991, 88, 7276–7280.
184. Heid, C.A.; Stevens, J.; Livak, K.J.; Williams, P.M. Real time quantitative PCR. Genome. Res. 1996, 6, 986–994.
185. Higuchi, R.; Fockler, C.; Dollinger, G.; Watson, R.: Kinetic PCR analysis: real-timemonitoring of DNA amplification reactions. Biotechnology (NY). 1993, 11, 1026–1030.
186. Wittwer, C.T.; Ririe, K.M.; Andrew, R.V.; David, D.A.; Gundry, R.A.; Balis, U.J. The LightCycler: a microvolumemultisample fluorimeter with rapid temperature control. Biotechniques. 1997, 22, 176–181.
187. Wittwer, C.T.; Herrmann, M.G.; Moss, A.A.; Rasmussen, R.P. Continuous fluorescence monitoring of rapid cycle DNA amplification. Biotechniques. 1997, 22, 130–131, 134–138.
188. Persing, D.H. Polymerase chain reaction: trenches to benches. J. Clin. Microbiol. 1991, 29, 1281–1285.
189. Longo, M.C.; Berninger, M.S.; Hartley, J.L. Use of uracil DNA glycosylase to control carryover contamination in polymerase chain reactions. Gene. 1990, 93, 125–128.
190. Tang, Y.W.; Mitchell, P.S.; Espy, M.J.; Smith, T.F.; Persing, D.H. Molecular diagnosis of herpes simplex virus infections in the central nervous system. J. Clin. Microbiol. 1999, 37, 2127–2136.
191. Wiedbrauk, D.L.; Cunningham, W. Stability of herpes simplex virus DNA in cerebrospinal fluid specimens. Diagn. Mol. Pathol. 1996, 5, 249–252.
192. Moudgil, T.; Daar, E.S. Infectious decay of human immunodeficiency virus type 1 in plasma. J. Infect. Dis. 1993, 167, 210–212.
193. Holodniy, M.; Mole, L.; Yen-Lieberman, B.; Margolis, D.; Starkey, C.; Carroll, R.; Spahlinger, T.; Todd, J.; Jackson, J.B.: Comparative stabilities of quantitative human immunodeficiency virus RNA in plasma from samples collected in VACUTAINER CPT, VACUTAINER PPT, and standard VACUTAINER tubes. J. Clin. Microbiol. 1995, 33, 1562–1566.
194. Rotbart, H.A.; Levin, M.J.; Villarreal, L.P.; Tracy, S.M.; Semler, B.L.; Wimmer, E.: Factors affecting the detection of enteroviruses in cerebrospinal fluid with coxsackievirus B3 and poliovirus 1 cDNA probes. J. Clin. Microbiol. 1985, 22, 220–224.
195. Ahmad, M.; Tashima, K.T.; Caliendo, A.M.; Flanigan, T.P. Cerebrospinal fluid and plasma HIV-1 RNA stability at 4 degrees C. AIDS. 1999, 13, 1281–1282.
196. Singer, E.J.; Aronow, H.A.; Lee, S.Y.; Hinkin, C.H.; Lazarus, T. Stability of human immunodeficiency virus type 1 RNA in cerebrospinal fluid determined with the AMPLICOR HIV- 1 MONITOR test, version 1.5 (ultrasensitive). J. Clin. Microbiol. 2002, 40, 3863–3864.
197. Aurelius, E.; Johnsson, B.; Skoldenberg, B.; Staland, A.; Forsgren, M. Rapid diagnosis of herpes simplex encephalitis by nested polymerase chain reaction assay of cerebrospinal fluid. Lancet. 1991, 337, 189–192.
198. Lakeman, F.D.; Whitley, R.J. Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J. Infect. Dis. 1995, 171, 857–863.
199. Linde, A.; Klapper, P.E.; Monteyne, P.; Echevarria, J.M.; Cinque, P.; Rozenberg, F.; Vestergaard, B.F.; Ciardi, M.; Lebon, P.; Cleator, G.M. Specific diagnostic methods for herpesvirus infections of the central nervous system: a consensus review by the European Union Concerted Action on Virus Meningitis and Encephalitis. Clin. Diagn. Virol. 1997, 8, 83–104.
200. Kimura, H.; Futamura, M.; Kito, H.; Ando, T.; Goto, M.; Kuzushima, K.; Shibata, M.; Morishima, T. Detection of viral DNA in neonatal herpes simplex virus infections: frequent and prolonged presence in serum and cerebrospinal fluid. J. Infect. Dis. 1991, 164, 289–293.
201. Kimberlin, D.W.; Lakeman, F.D.; Arvin, A.M.; Prober, C.G.; Corey, L.; Powell, D.A.; Burchett, S.K.; Jacobs, R.F.; Starr, S.E.; Whitley, R.J.: Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J. Infect. Dis. 1996, 174, 1162–1167.
202. Aurelius, E.; Johansson, B.; Skoldenberg, B.; Forsgren, M.: Encephalitis in immunocompetent patients due to herpes simplex virus type 1 or 2 as determined by type-specific polymerase chain reaction and antibody assays of cerebrospinal fluid. J. Med. Virol. 1993, 39, 179–186.
203. Schlesinger, Y.; Tebas, P.; Buller, R.S.; Storch, G.A. Herpes simplex virus type 2 meningitis in the absence of genital lesions: improved recognition with use of the polymerase chain reaction. Clin. Infect. Dis. 1995, 20, 842–848.
204. Puchhammer-Stockl, E.; Popow-Kraupp, T.; Heinz, F.X.; Mandl, C.W.; Kunz, C. Detection of varicella-zoster virus DNA by polymerase chain reaction in the cerebrospinal fluid of patients suffering from neurological complications associated with chicken pox or herpes zoster. J. Clin. Microbiol. 1991, 29, 1513–1516.
205. Echevarria, J.M.; Casas, I.; Tenorio, A.; de Ory, F.; Martinez-Martin, P.: Detection of varicellazoster virus-specific DNA sequences in cerebrospinal fluid from patients with acute aseptic meningitis and no cutaneous lesions. J. Med. Virol. 1994, 43, 331–335.
206. Haanpaa, M.; Dastidar, P.; Weinberg, A.; Levin, M.; Miettinen, A.; Lapinlampi, A.; Laippala, P.; Nurmikko, T.: CSF and MRI findings in patients with acute herpes zoster. Neurology. 1998, 51, 1405–1411.
207. Darin, N.; Bergstrom, T.; Fast, A.; Kyllerman, M. Clinical, serological and PCR evidence of cytomegalovirus infection in the central nervous system in infancy and childhood. Neuropediatrics. 1994, 25, 316–322.
208. Troendle Atkins, J.; Demmler, G.J.; Williamson, W.D.; McDonald, J.M.; Istas, A.S.; Buffone, G.J. Polymerase chain reaction to detect cytomegalovirus DNA in the cerebrospinal fluid of neonates with congenital infection. J. Infect. Dis. 1994, 169, 1334–1337.
209. Imai, S.; Usui, N.; Sugiura, M.; Osato, T.; Sato, T.; Tsutsumi, H.; Tachi, N.; Nakata, S.; Yamanaka, T.; Chiba, S. Epstein-Barr virus genomic sequences and specific antibodies in cerebrospinal fluid in children with neurologic complications of acute and reactivated EBV infections. J. Med. Virol. 1993, 40, 278–284.
210. Landgren, M.; Kyllerman, M.; Bergstrom, T.; Dotevall, L.; Ljungstrom, L.; Ricksten, A. Diagnosis of Epstein-Barr virus-induced central nervous system infections by DNA amplification from cerebrospinal fluid. Ann. Neurol. 1994, 35, 631–635.
211. Weinberg, A.; Li, S.; Palmer, M.; Tyler, K.L. Quantitative CSF PCR in Epstein-Barr virus infections of the central nervous system. Ann. Neurol. 2002, 2, 543–548.
212. Caserta, M.T.; Hall, C.B.; Schnabel, K.; McIntyre, K.; Long, C.; Costanzo, M.; Dewhurst, S.; Insel, R.; Epstein, L.G.: Neuroinvasion and persistence of human herpesvirus 6 in children. J. Infect. Dis. 1994, 170, 1586–1589.
213. Hall, C.B.; Caserta, M.T.; Schnabel, K.C.; Long, C.; Epstein, L.G.; Insel, R.A.; Dewhurst, S. Persistence of human herpesvirus 6 according to site and variant: possible greater neurotropism of variant A. Clin. Infect. Dis. 1998, 26, 132–137.
214. Torigoe, S.; Koide, W.; Yamada, M.; Miyashiro, E.; Tanaka-Taya, K.; Yamanishi, K. Human herpesvirus 7 infection associated with central nervous system manifestations. J. Pediatr. 1996, 129, 301–305.
215. van den Berg, J.S.; van Zeijl, J.H.; Rotteveel, J.J.; Melchers, W.J.; Gabreels, F.J.; Galama, J.M. Neuroinvasion by human herpesvirus type 7 in a case of exanthem subitum with severe neurologic manifestations. Neurology. 1999, 52, 1077–1079.
216. Yoshikawa, T.; Ihira, M.; Suzuki, K.; Suga, S.; Matsubara, T.; Furukawa, S.; Asano, Y. Invasion by human herpesvirus 6 and human herpesvirus 7 of the central nervous system in patients with neurological signs and symptoms. Arch. Dis. Child. 2000, 83, 170–171.
217. Pohl-Koppe, A.; Blay, M.; Jager, G.; Weiss, M. Human herpes virus type 7 DNA in the cerebrospinal fluid of children with central nervous system diseases. Eur. J. Pediatr. 2001, 160, 351–358.
218. Steininger, C.; Popow-Kraupp, T.; Laferl, H.; Seiser, A.; Godl, I.; Djamshidian, S.; Puchhammer-Stockl, E. Acute encephalopathy associated with influenza A virus infection. Clin. Infect. Dis. 2003, 36, 567–574.
219. Voltz, R.; Jager, G.; Seelos, K.; Fuhry, L.; Hohlfeld, R. BK virus encephalitis in an immunocompetent patient. Arch. Neurol. 1996, 53, 101–103.
220. Behzad-Behbahani, A.; Klapper, P.E.; Vallely, P.J.; Cleator, G.M.: BK virus DNA in CSF of immunocompetent and immunocompromised patients. Arch. Dis. Child. 2003, 88, 174–175.
221. Druschky, K.; Walloch, J.; Heckmann, J.; Schmidt, B.; Stefan, H.; Neundorfer, B. Chronic parvovirus B-19 meningoencephalitis with additional detection of Epstein-Barr virus DNA in the cerebrospinal fluid of an immunocompetent patient. J. Neurovirol. 2000, 6, 418–422.
222. Okumura, A.; Ichikawa, T. Aseptic meningitis caused by human parvovirus B19. Arch. Dis. Child. 1993, 68, 784–785.
223. Nishimura, S.; Ushijima, H.; Nishimura, S.; Shiraishi, H.; Kanazawa, C.; Abe, T.; Kaneko, K.; Fukuyama, Y. Detection of rotavirus in cerebrospinal fluid and blood of patients with convulsions and gastroenteritis by means of the reverse transcription polymerase chain reaction. Brain. Dev. 1993, 15, 457–459.
224. Keidan, I.; Shif, I.; Keren, G.; Passwell, J.H. Rotavirus encephalopathy: evidence of central nervous system involvement during rotavirus infection. Pediatr. Infect. Dis. J. 1992, 11, 773–775.
225. Abe, T.; Kobayashi, M.; Araki, K.; Kodama, H.; Fujita, Y.; Shinozaki, T.; Ushijima, H. Infantile convulsions with mild gastroenteritis. Brain. Dev. 2000, 22, 301–306.
226. Glimaker, M.; Johansson, B.; Olcen, P.; Ehrnst, A.; Forsgren, M. Detection of enteroviral RNA by polymerase chain reaction in cerebrospinal fluid from patients with aseptic meningitis. Scand. J. Infect. Dis. 1993, 25, 547–557.
227. Jeffery, K.J.; Read, S.J.; Peto, T.E.; Mayon-White, R.T.; Bangham, C.R. Diagnosis of viral infections of the central nervous system: clinical interpretation of PCR results. Lancet. 1997, 349, 313–317.
228. Date, M.; Gondoh, M.; Kato, S.; Fukushima, M.; Nakamoto, N.; Kobayashi, M.; Abe, T. A case of rubella encephalitis: rubella virus genome was detected in the cerebrospinal fluid by polymerase chain reaction. No. To. Hattatsu. 1995, 27, 286–290.
229. Fujimoto, S.; Kobayashi, M.; Uemura, O.; Iwasa, M.; Ando, T.; Katoh, T.; Nakamura, C.; Maki, N.; Togari, H.; Wada, Y. PCR on cerebrospinal fluid to show influenza-associated acute encephalopathy or encephalitis. Lancet. 1998, 352, 873–875.
230. Ito, Y.; Ichiyama, T.; Kimura, H.; Shibata, M.; Ishiwada, N.; Kuroki, H.; Furukawa, S.; Morishima, T.: Detection of influenza virus RNA by reverse transcription-PCR and proinflammatory cytokines in influenza-virus-associated encephalopathy. J. Med. Virol. 1999, 58, 420–425.
231. Togashi, T.; Matsuzono, Y.; Narita, M. Epidemiology of influenza-associated encephalitisencephalopathy in Hokkaido, the northernmost island of Japan. Pediatr. Int. 2000, 42, 192–196.
232. Tomoda, A.; Shiraishi, S.; Hosoya, M.; Hamada, A.; Miike, T.: Combined treatment with interferon-alpha and ribavirin for subacute sclerosing panencephalitis. Pediatr. Neurol. 2001, 24, 54–59.
233. Nakayama, T.; Mori, T.; Yamaguchi, S.; Sonoda, S.; Asamura, S.; Yamashita, R.; Takeuchi, Y.; Urano, T. Detection of measles virus genome directly from clinical samples by reverse transcriptase-polymerase chain reaction and genetic variability. Virus. Res. 1995, 35, 1–16.
234. Matsuzono, Y.; Narita, M.; Ishiguro, N.; Togashi, T. Detection of measles virus from clinical samples using the polymerase chain reaction. Arch. Pediatr. Adolesc. Med. 1994, 148, 289–293.
235. Wacharapluesadee, S.; Hemachudha, T. Nucleic-acid sequence based amplification in the rapid diagnosis of rabies. Lancet. 2001, 358, 892–893.
236. Crepin, P.; Audry, L.; Rotivel, Y.; Gacoin, A.; Caroff, C.; Bourhy, H.: Intravitam diagnosis of human rabies by PCR using saliva and cerebrospinal fluid. J. Clin. Microbiol. 1998, 36, 1117–1121.
237. Gunther, S.; Weisner, B.; Roth, A.; Grewing, T.; Asper, M.; Drosten, C.; Emmerich, P.; Petersen, J.; Wilczek, M.; Schmitz, H. Lassa fever encephalopathy: Lassa virus in cerebrospinal fluid but not in serum. J. Infect. Dis. 2001, 184, 345–349.
238. Cavrois, M.; Gessain, A.; Gout, O.; Wain-Hobson, S.; Wattel, E.: Common human T cell leukemia virus type 1 (HTLV-1) integration sites in cerebrospinal fluid and blood lymphocytes of patients with HTLV-1-associated myelopathy/tropical spastic paraparesis indicate that HTLV-1 crosses the blood-brain barrier via clonal HTLV-1-infected cells. J. Infect. Dis. 2000, 182, 1044–1050.
239. Nagai, M.; Yamano, Y.; Brennan, M.B.; Mora, C.A.; Jacobson, S.: Increased HTLV-I proviral load and preferential expansion of HTLV-I Tax-specific CD8+T cells in cerebrospinal fluid from patients with HAM/TSP. Ann. Neurol. 2001, 50, 807–812.
240. Kompoliti, A.; Gage, B.; Sharma, L.; Daniels, J.C.: Human T-cell lymphotropic virus type 1-associated myelopathy, Sjogren syndrome, and lymphocytic pneumonitis. Arch. Neurol. 1996, 53, 940–942.
241. Yang, Y.C.; Hung, T.P.; Wang, C.H.; Lin, M.T.; Hsu, T.Y.; Chen, J.Y.; Chen, Y.C.; Yang, C.S.: Establishment and characterization of an HTLV-1 cell line from a Taiwanese patient with HTLV-1-associated myelopathy. J. Neurol. Sci. 1993, 120, 46–53.
242. Valassina, M.; Cusi, M.G.; Valensin, P.E. Rapid identification of Toscana virus by nested PCR during an outbreak in the Siena area of Italy. J. Clin. Microbiol. 1996, 34, 2500–2502.
243. Echevarria, J.M.; de Ory, F.; Guisasola, M.E.; Sanchez-Seco, M.P.; Tenorio, A.; Lozano, A.; Cordoba, J.; Gobernado, M.: Acute meningitis due to Toscana virus infection among patients from both the Spanish Mediterranean region and the region of Madrid. J. Clin. Virol. 2003, 26, 79–84.
244. Huang, C.; Campbell, W.; Grady, L.; Kirouac, I.; LaForce, F.M. Diagnosis of Jamestown Canyon encephalitis by polymerase chain reaction. Clin. Infect. Dis. 1999, 28, 1294–1297.
245. Huang, C.; Chatterjee, N.K.; Grady, L.J. Diagnosis of viral infections of the central nervous system. N. Engl. J. Med. 1999, 340, 483–484.
246. Cam, B.V.; Fonsmark, L.; Hue, N.B.; Phuong, N.T.; Poulsen, A.; Heegaard, E.D. Prospective case-control study of encephalopathy in children with dengue hemorrhagic fever. Am. J. Trop. Med. Hyg. 2001, 65, 848–851.
247. Petersen, L.R.; Marfin, A.A. West Nile virus: a primer for the clinician. Ann. Intern. Med. 2002, 6, 173–179.
248. Briese, T.; Glass, W.G.; Lipkin, W.I. Detection of West Nile virus sequences in cerebrospinal fluid. Lancet. 2000, 355, 1614–1615.
249. Laskus, T.; Radkowski, M.; Bednarska, A.; Wilkinson, J.; Adair, D.; Nowicki, M.; Nikolopoulou, G.B.; Vargas, H.; Rakela, J.: Detection and analysis of hepatitis C virus sequences in cerebrospinal fluid. J. Virol. 2002, 76, 10064–10068.
250. Maggi, F.; Giorgi, M.; Fornai, C.; Morrica, A.; Vatteroni, M.L.; Pistello, M.; Siciliano, G.; Nuccorini, A.; Bendinelli, M.: Detection and quasispecies analysis of hepatitis C virus in the cerebrospinal fluid of infected patients. J. Neurovirol. 1999, 5, 319–323.
251. Dessau, R.B.; Lisby, G.; Frederiksen, J.L. Coronaviruses in spinal fluid of patients with acute monosymptomatic optic neuritis. Acta. Neurol. Scand. 1999, 100, 88–91.
252. Cristallo, A.; Gambaro, F.; Biamonti, G.; Ferrante, P.; Battaglia, M.; Cereda, P.M. Human coronavirus polyadenylated RNA sequences in cerebrospinal fluid from multiple sclerosis patients. New Microbiol. 1997, 20, 105–114.
253. Tan, S.V.; Guiloff, R.J.; Scaravilli, F.; Klapper, P.E.; Cleator, G.M.; Gazzard, B.G. Herpes simplex type 1 encephalitis in acquired immunodeficiency syndrome. Ann. Neurol. 1993, 34, 619–622.
254. Miller, R.F.; Fox, J.D.; Waite, J.C.; Severn, A.; Brink, N.S. Herpes simplex virus type 2 encephalitis and concomitant cytomegalovirus infection in a patient with AIDS: detection of virus-specific DNA in CSF by nested polymerase chain reaction. Genitourin. Med. 1995, 71, 262–264.
255. Burke, D.G.; Kalayjian, R.C.; Vann, V.R.; Madreperla, S.A.; Shick, H.E.; Leonard, D.G.: Polymerase chain reaction detection and clinical significance of varicella-zoster virus in cerebrospinal fluid from human immunodeficiency virus-infected patients. J. Infect. Dis. 1997, 176, 1080–1084.
256. Cinque, P.; Bossolasco, S.; Vago, L.; Fornara, C.; Lipari, S.; Racca, S.; Lazzarin, A.; Linde, A. Varicella-zoster virus (VZV) DNA in cerebrospinal fluid of patients infected with human immunodeficiency virus: VZV disease of the central nervous system or subclinical reactivation of VZV infection?. Clin. Infect. Dis. 1997, 25, 634–639.
257. Iten, A.; Chatelard, P.; Vuadens, P.; Miklossy, J.; Meuli, R.; Sahli, R.; Meylan, P.R. Impact of cerebrospinal fluid PCR on the management of HIV-infected patients with varicella-zoster virus infection of the central nervous system. J. Neurovirol. 1999, 5, 172–180.
258. Wolf, D.G.; Spector, S.A. Diagnosis of human cytomegalovirus central nervous system disease in AIDS patients by DNA amplification from cerebrospinal fluid. J. Infect. Dis. 1992, 166, 1412–1415.
259. Cinque, P.; Vago, L.; Brytting, M.; Castagna, A.; Accordini, A.; Sundqvist, V.A.; Zanchetta, N.; Monforte, A.D.; Wahren, B.; Lazzarin, A. Cytomegalovirus infection of the central nervous system in patients with AIDS: diagnosis by DNA amplification from cerebrospinal fluid. J. Infect. Dis. 1992, 166, 1408–1411.
260. Gozlan, J.; Salord, J.M.; Roullet, E.; Baudrimont, M.; Caburet, F.; Picard, O.; Meyohas, M.C.; Duvivier, C.; Jacomet, C.; Petit, J.C. Rapid detection of cytomegalovirus DNA in cerebrospinal fluid of AIDS patients with neurologic disorders. J. Infect. Dis. 1992, 166, 1416–1421.
261. Clifford, D.B.; Buller, R.S.; Mohammed, S.; Robinson, L.; Storch, G.A. Use of polymerase chain reaction to demonstrate cytomegalovirus DNA in CSF of patients with human immunodeficiency virus infection. Neurology. 1993, 43, 75–79.
262. Fox, J.D.; Brink, N.S.; Zuckerman, M.A.; Neild, P.; Gazzard, B.G.; Tedder, R.S.; Miller, R.F. Detection of herpesvirus DNA by nested polymerase chain reaction in cerebrospinal fluid of human immunodeficiency virus-infected persons with neurologic disease: a prospective evaluation. J. Infect. Dis. 1995, 172, 1087–1090.
263. Cinque, P.; Brytting, M.; Vago, L.; Castagna, A.; Parravicini, C.; Zanchetta, N.; D’Arminio Monforte, A.; Wahren, B.; Lazzarin, A.; Linde, A. Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system. Lancet. 1993, 342, 398–401.
264. Arribas, J.R.; Clifford, D.B.; Fichtenbaum, C.J.; Roberts, R.L.; Powderly, W.G.; Storch, G.A. Detection of Epstein-Barr virus DNA in cerebrospinal fluid for diagnosis of AIDS-related central nervous system lymphoma. J. Clin. Microbiol. 1995, 33, 1580–1583.
265. De Luca, A.; Antinori, A.; Cingolani, A.; Larocca, L.M.; Linzalone, A.; Ammassari, A.; Scerrati, M.; Roselli, R.; Tamburrini, E.; Ortona, L.: Evaluation of cerebrospinal fluid EBVDNA and IL-10 as markers for in vivo diagnosis of AIDS-related primary central nervous system lymphoma. Br. J. Haematol. 1995, 90, 844–849.
266. Knox, K.K.; Harrington, D.P.; Carrigan, D.R. Fulminant human herpesvirus six encephalitis in a human immunodeficiency virus-infected infant. J. Med. Virol. 1995, 45, 288–292.
267. Wang, F.Z.; Linde, A.; Hagglund, H.; Testa, M.; Locasciulli, A.; Ljungman, P. Human herpesvirus 6 DNA in cerebrospinal fluid specimens from allogeneic bone marrow transplant patients: does it have clinical significance?. Clin. Infect. Dis. 1999, 28, 562–568.
268. Bossolasco, S.; Marenzi, R.; Dahl, H.; Vago, L.; Terreni, M.R.; Broccolo, F.; Lazzarin, A.; Linde, A.; Cinque, P. Human herpesvirus 6 in cerebrospinal fluid of patients infected with HIV: frequency and clinical significance. J. Neurol Neurosurg Psychiatry. 1999, 67, 789–792.
269. Weber, T.; Turner, R.W.; Frye, S.; Ruf, B.; Haas, J.; Schielke, E.; Pohle, H.D.; Luke, W.; Luer, W.; Felgenhauer, K. Specific diagnosis of progressive multifocal leukoencephalopathy by polymerase chain reaction. J. Infect. Dis. 1994, 169, 1138–1141.
270. Fong, I.W.; Britton, C.B.; Luinstra, K.E.; Toma, E.; Mahony, J.B. Diagnostic value of detecting J. C. virus DNAin cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. J. Clin. Microbiol. 1995, 33, 484–486.
271. McGuire, D.; Barhite, S.; Hollander, H.; Miles, M. J. C. virus DNA in cerebrospinal fluid of human immunodeficiency virus-infected patients: predictive value for progressive multifocal leukoencephalopathy. Ann. Neurol. 1995, 37, 395–399.
272. Cinque, P.; Scarpellini, P.; Vago, L.; Linde, A.; Lazzarin, A. Diagnosis of central nervous system complications in HIV-infected patients: cerebrospinal fluid analysis by the polymerase chain reaction. AIDS. 1997, 11, 1–17.
273. Bratt, G.; Hammarin, A.L.; Grandien, M.; Hedquist, B.G.; Nennesmo, I.; Sundelin, B.; Seregard, S. B. K. virus as the cause of meningoencephalitis, retinitis and nephritis in a patient with AIDS. AIDS. 1999, 13, 1071–1075.
274. Morsica, G.; Bernardi, M.T.; Novati, R.; Uberti Foppa, C.; Castagna, A.; Lazzarin, A. Detection of hepatitis C virus genomic sequences in the cerebrospinal fluid of HIV-infected patients. J. Med. Virol. 1997, 53, 252–254.
275. Gazzola, P.; Mavilio, D.; Costa, P.; Fogli, M.; Bruzzone, B.; Icardi, G.; Primavera, A.; Cocito, L.; De Maria, A. Possible hepatitis C virus involvement in acute meningoradiculitis/polyradiculitis of HIV-1-co-infected patients. AIDS. 2001, 15, 539–541.
276. Oberste, M.S.; Maher, K.; Pallansch, M.A. Complete sequence of echovirus 23 and its relationship to echovirus 22 and other human enteroviruses. Virus. Res. 1998, 56, 217–223.
277. Rotbart, H.A.; Sawyer, M.H.; Fast, S.; Lewinski, C.; Murphy, N.; Keyser, E.F.; Spadoro, J.; Kao, S.Y.; Loeffelholz, M. Diagnosis of enteroviral meningitis by using PCR with a colorimetric microwell detection assay. J. Clin. Microbiol. 1994, 32, 2590–2592.
278. Lina, B.; Pozzetto, B.; Andreoletti, L.; Beguier, T.; Bourlet, T.; Dussaix, E.; Grangeot-Keros, L.; Gratacap-Cavallier, B.; Henquell, C.; Legrand-Quillien, M.C.; Novillo, A.; Palmer, P.; Petitjean, J.; Sandres, K.; Dubreuil, P. Multicenter evaluating of a commercially available PCR assay for diagnosing enterovirus infection in a panel of cerebrospinal fluid specimens. J. Clin. Microbiol. 1996, 34, 3002–3006.
279. Romero, J.R.: Reverse-transcription polymerase chain reaction detection of the enteroviruses. Arch. Pathol. Lab. Med. 1999, 123, 1161–1169.
280. Cinque, P.; Vago, L.; Dahl, H.; Brytting, M.; Terreni, M.R.; Fornara, C.; Racca, S.; Castagna, A.; Monforte, A.D.; Wahren, B.; Lazzarin, A.; Linde, A. Polymerase chain reaction on cerebrospinal fluid for diagnosis of virus-associated opportunistic diseases of the central nervous system in HIV-infected patients. AIDS. 1996, 10, 951–958.
281. de Luca, A.; Cingolani, A.; Linzalone, A.; Ammassari, A.; Murri, R.; Giancola, M.L.; Maiuro, G.; Antinori, A. Improved detection of JC virus DNA in cerebrospinal fluid for diagnosis of AIDS-related progressive multifocal leukoencephalopathy. J. Clin. Microbiol. 1996, 34, 1343–1346.
282. Miralles, P.; Berenguer, J.; Garcia de Viedma, D.; Padilla, B.; Cosin, J.; Lopez-Bernaldo de Quiros, J.C.; Munoz, L.; Moreno, S.; Bouza, E.: Treatment of AIDS-associated progressive multifocal leukoencephalopathy with highly active antiretroviral therapy. AIDS. 1998, 12, 2467–2472.
283. Giudici, B.; Vaz, B.; Bossolasco, S.; Casari, S.; Brambilla, A.M.; Luke, W.; Lazzarin, A.; Weber, T.; Cinque, P. Highly active antiretroviral therapy and progressive multifocal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response. Clin. Infect. Dis. 2000, 30, 95–99.
284. MacMahon, E.M.; Glass, J.D.; Hayward, S.D.; Mann, R.B.; Becker, P.S.; Charache, P.; McArthur, J.C.; Ambinder, R.F. Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet. 1991, 338, 969–973.
285. Cingolani, A.; Gastaldi, R.; Fassone, L.; Pierconti, F.; Giancola, M.L.; Martini, M.; De Luca, A.; Ammassari, A.; Mazzone, C.; Pescarmona, E.; Gaidano, G.; Larocca, L.M.; Antinori, A. Epstein-Barr virus infection is predictive of CNS involvement in systemic AIDS-related non- Hodgkin’s lymphomas. J. Clin. Oncol. 2000, 18, 3325–3330.
286. Ando, Y.; Kimura, H.; Miwata, H.; Kudo, T.; Shibata, M.; Morishima, T. Quantitative analysis of herpes simplex virus DNA in cerebrospinal fluid of children with herpes simplex encephalitis. J. Med. Virol. 1993, 41, 170–173.
287. Revello, M.G.; Baldanti, F.; Sarasini, A.; Zella, D.; Zavattoni, M.; Gerna, G. Quantitation of herpes simplex virus DNA in cerebrospinal fluid of patients with herpes simplex encephalitis by the polymerase chain reaction. Clin. Diagn. Virol. 1997, 7, 183–191.
288. Domingues, R.B.; Lakeman, F.D.; Mayo, M.S.; Whitley, R.J. Application of competitive PCR to cerebrospinal fluid samples from patients with herpes simplex encephalitis. J. Clin. Microbiol. 1998, 36, 2229–2234.
289. Kessler, H.H.; Muhlbauer, G.; Rinner, B.; Stelzl, E.; Berger, A.; Dorr, H.W.; Santner, B.; Marth, E.; Rabenau, H. Detection of herpes simplex virus DNA by real-time PCR. J. Clin. Microbiol. 2000, 38, 2638–2642.
290. Kimura, H.; Ito, Y.; Futamura, M.; Ando, Y.; Yabuta, Y.; Hoshino, Y.; Nishiyama, Y.; Morishima, T. Quantitation of viral load in neonatal herpes simplex virus infection and comparison between type 1 and type 2. J. Med. Virol. 2002, 67, 349–353.
291. Aberle, S.W.; Puchhammer-Stockl, E. Diagnosis of herpesvirus infections of the central nervous system. J. Clin. Virol. 2002, 25(Suppl 1), S79–S85.
292. Arribas, J.R.; Clifford, D.B.; Fichtenbaum, C.J.; Commins, D.L.; Powderly, W.G.; Storch, G.A.: Level of cytomegalovirus (CMV) DNA in cerebrospinal fluid of subjects with AIDS and CMV infection of the central nervous system. J. Infect. Dis. 1995, 172, 527–531.
293. Cinque, P.; Baldanti, F.; Vago, L.; Terreni, M.R.; Lillo, F.; Furione, M.; Castagna, A.; Monforte, A.D.; Lazzarin, A.; Linde, A. Ganciclovir therapy for cytomegalovirus (CMV) infection of the central nervous system in AIDS patients: monitoring by CMV DNA detection in cerebrospinal fluid. J. Infect. Dis. 1995, 171, 1603–1606.
294. Shinkai, M.; Spector, S.A. Quantitation of human cytomegalovirus (HCMV) DNA in cerebrospinal fluid by competitive PCR in AIDS patients with different HCMV central nervous system diseases. Scand. J. Infect. Dis. 1995, 27, 559–561.
295. Bossolasco, O.; Cinque, P.; Ponzoni, M.; Vigano, M.G.; Lazzarin, A.; Linde, A.; Falk, K.I. Epstein-Barr virus DNA load in cerebrospinal fluid and plasma of patients with AIDS-related lymphoma. J. Neurovirol. 2002, 8, 432–438.
296. Taoufik, Y.; Gasnault, J.; Karaterki, A.; Pierre Ferey, M.; Marchadier, E.; Goujard, C.; Lannuzel, A.; Delfraissy, J.F. E.: Dussaix, Prognostic value of JC virus load in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. J. Infect. Dis. 1998, 178, 1816–1820.
297. Koralnik, I.J.; Boden, D.; Mai, V.X.; Lord, C.I.; Letvin, N.L. J. C. virus DNA load in patients with and without progressive multifocal leukoencephalopathy. Neurology. 1999, 52, 253–260.
298. Yiannoutsos, C.T.; Major, E.O.; Curfman, B.; Jensen, P.N.; Gravell, M.; Hou, J.; Clifford, D.B.; Hall, C.D. Relation of J. C. virus DNA in the cerebrospinal fluid to survival in acquired immunodeficiency syndrome patients with biopsy-proven progressive multifocal leukoencephalopathy. Ann. Neurol. 1999, 45, 816–821.
299. Garcia de Viedma, D.; Alonso, R.; Miralles, P.; Berenguer, J.; Rodriguez-Creixems, M.; Bouza, E. Dual qualitative-quantitative nested PCR for detection of JC virus in cerebrospinal fluid: high potential for evaluation and monitoring of progressive multifocal leukoencephalopathy in AIDS patients receiving highly active antiretroviral therapy. J. Clin. Microbiol. 1999, 37, 724–728.
300. Eggers, C.; Stellbrink, H.J.; Buhk, T.; Dorries, K. Quantification of JC virus DNA in the cerebrospinal fluid of patients with human immunodeficiency virus-associated progressive multifocal leukoencephalopathy—a longitudinal study. J. Infect. Dis. 1999, 180, 1690–1694.
301. Martino, T.A.; Sole, M.J.; Penn, L.Z.; Liew, C.C.; Liu, P. Quantitation of enteroviral RNA by competitive polymerase chain reaction. J. Clin. Microbiol. 1993, 31, 2634–2640.
302. Arola, A.; Santti, J.; Ruuskanen, O.; Halonen, P.; Hyypia, T. Identification of enteroviruses in clinical specimens by competitive PCR followed by genetic typing using sequence analysis. J. Clin. Microbiol. 1996, 34, 313–318.
303. Verstrepen, W.A.; Kuhn, S.; Kockx, M.M.; Van De Vyvere, M.E.; Mertens, A.H. Rapid detection of enterovirus RNA in cerebrospinal fluid specimens with a novel single-tube realtime reverse transcription-PCR assay. J. Clin. Microbiol. 2001, 39, 4093–4096.
304. Brew, B.J.; Pemberton, L.; Cunningham, P.; Law, M.G. Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage. J. Infect. Dis. 1997, 175, 963–966.
305. Ellis, R.J.; Hsia, K.; Spector, S.A.; Nelson, J.A.; Heaton, R.K.; Wallace, M.R.; Abramson, I.; Atkinson, J.H.; Grant, I.; McCutchan, J.A.: Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group. Ann. Neurol. 1997, 42, 679–688.
306. Cinque, P.; Vago, L.; Ceresa, D.; Mainini, F.; Terreni, M.R.; Vagani, A.; Torri, W.; Bossolasco, S.; Lazzarin, A. Cerebrospinal fluid HIV-1 RNA levels: correlation with HIV encephalitis. AIDS. 1998, 12, 389–394.
307. Gisslen, M.; Norkrans, G.; Svennerholm, B.; Hagberg, L. The effect on human immunodeficiency virus type 1 RNA levels in cerebrospinal fluid after initiation of zidovudine or didanosine. J. Infect. Dis. 1997, 175, 434–437.
308. Foudraine, N.A.; Hoetelmans, R.M.; Lange, J.M.; de Wolf, F.; van Benthem, B.H.; Maas, J.J.; Keet, I.P.; Portegies, P. Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine. Lancet. 1998, 351, 1547–1551.
309. Staprans, S.; Marlowe, N.; Glidden, D.; Novakovic-Agopian, T.; Grant, R.M.; Heyes, M.; Aweeka, F.; Deeks, S.; Price, R.W. Time course of cerebrospinal fluid responses to antiretroviral therapy: evidence for variable compartmentalization of infection. AIDS. 1999, 13, 1051–1061.
310. Ellis, R.J.; Gamst, A.C.; Capparelli, E.; Spector, S.A.; Hsia, K.; Wolfson, T.; Abramson, I.; Grant, I.; McCutchan, J.A. Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources. Neurology. 2000, 54, 927–936.
311. Gisolf, E.H.; Enting, R.H.; Jurriaans, S.; de Wolf, F.; van der Ende, M.E.; Hoetelmans, R.M.; Portegies, P.; Danner, S.A. Cerebrospinal fluid HIV-1 RNA during treatment with ritonavir/saquinavir or ritonavir/saquinavir/stavudine. AIDS. 2000, 14, 1583–1589.
312. Cinque, P.; Bestetti, A.; Morelli, P.; Presi, S. Molecular analysis of cerebrospinal fluid: potential for the study of HIV-1 infection of the central nervous system. J. Neurovirol. 2000, 6(suppl 1), S95–S102.
313. Price, R.W.; Paxinos, E.E.; Grant, R.M.; Drews, B.; Nilsson, A.; Hoh, R.; Hellmann, N.S.; Petropoulos, C.J.; Deeks, S.G. Cerebrospinal fluid response to structured treatment interruption after virological failure. AIDS. 2001, 15, 1251–1259.
314. Cinque, P.; Presi, S.; Bestetti, A.; Pierotti, C.; Racca, S.; Boeri, E.; Morelli, P.; Carrera, P.; Ferrari, M.; Lazzarin, A. Effect of genotypic resistance on the virological response to highly active antiretroviral therapy in cerebrospinal fluid. AIDS Res. Hum. Retroviruses. 2001, 17, 377–383.
315. Tang, Y.W.; Espy, M.J.; Persing, D.H.; Smith, T.F.: Molecular evidence and clinical significance of herpesvirus coinfection in the central nervous system. J. Clin. Microbiol. 1997, 35, 2869–2872.
316. Studahl, M.; Bergstrom, T.; Hagberg, L. Acute viral encephalitis in adults—a prospective study. Scand. J. Infect. Dis. 1998, 30, 215–220.
317. Portolani, M.; Sabbatini, A.M.; Meacci, M.; Pietrosemoli, P.; Cermelli, C.; Lunghi, P.; Golinelli, F.; Stacca, R. Epstein-Barr virus DNA in cerebrospinal fluid from an immunocompetent man with herpes simplex virus encephalitis. J. Neurovirol. 1998, 4, 461–464.
318. Liedtke, W.; Malessa, R.; Faustmann, P.M.; Eis-Hubinger, A.M.: Human herpesvirus 6 polymerase chain reaction findings in human immunodeficiency virus associated neurological disease and multiple sclerosis. J. Neurovirol. 1995, 1, 253–258.
319. Ferrante, P.; Omodeo-Zorini, E.; Caldarelli-Stefano, R.; Mediati, M.; Fainardi, E.; Granieri, E.; Caputo, D. Detection of J. C. virus DNA in cerebrospinal fluid from multiple sclerosis patients. Mult. Scler. 1998, 4, 49–54.
320. Ross, J.S.: Financial determinants of outcomes in molecular testing. Arch. Pathol. Lab. Med. 1999, 123, 1071–1075.
321. Tebas, P.; Nease, R.F.; Storch, G.A. Use of the polymerase chain reaction in the diagnosis of herpes simplex encephalitis: a decision analysis model. Am. J. Med. 1998, 105, 287–295.
322. Swingler, G.; Delport, S.; Hussey, G. An audit of the use of antibiotics in presumed viral meningitis in children. Pediatr. Infect. Dis. J. 1994, 13, 1107–1110.
323. Rice, S.K.; Heinl, R.E.; Thornton, L.L.; Opal, S.M.: Clinical characteristics, management strategies, and cost implications of a statewide outbreak of enterovirus meningitis. Clin. Infect. Dis. 1995, 20, 931–937.
324. Marshall, G.S.; Hauck, M.A.; Buck, G.; Rabalais, G.P. Potential cost savings through rapid diagnosis of enteroviral meningitis. Pediatr. Infect. Dis. J. 1997, 16, 1086–1087.
325. van Vliet, K.E.; Glimaker, M.; Lebon, P.; Klapper, P.E.; Taylor, C.E.; Ciardi, M.; van der Avoort, H.G.; Diepersloot, R.J.; Kurtz, J.; Peeters, M.F.; Cleator, G.M.; van Loon, A.M. Multicenter evaluation of the Amplicor enterovirus PCR test with cerebrospinal fluid from patients with aseptic meningitis. The European Union Concerted Action on Viral Meningitis and Encephalitis. J. Clin. Microbiol. 1998, 36, 2652–2657.
326. Muir, P.; Ras, A.; Klapper, P.E.; Cleator, G.M.; Korn, K.; Aepinus, C.; Fomsgaard, A.; Palmer, P.; Samuelsson, A.; Tenorio, A.; Weissbrich, B.; van Loon, A.M. Multicenter quality assessment of PCR methods for detection of enteroviruses. J. Clin. Microbiol. 1999, 37, 1409–1414.
327. van Loon, A.M.; Cleator, G.C.; Ras, A. External quality assessment of enterovirus detection and typing. European Union Concerted Action on Virus Meningitis and Encephalitis. Bull World Health Org. 1999, 77, 217–223.
328. Weber, T.; Klapper, P.E.; Cleator, G.M.; Bodemer, M.; Luke, W.; Knowles, W.; Cinque, P.; Van Loon, A.M.; Grandien, M.; Hammarin, A.L.; Ciardi, M.; Bogdanovic, G. Polymerase chain reaction for detection of J. C. virus DNA in cerebrospinal fluid: a quality control study. European Union Concerted Action on Viral Meningitis and Encephalitis. J. Virol. Methods. 1997, 69, 231–237.
329. Schloss, L.; van Loon, A.M.; Cinque, P.; Cleator, G.; Echevarria, J.M.; Falk, K.I.; Klapper, P.; Schirm, J.; Vestergaard, B.F.; Niesters, B.; Popow-Kraupp, T.; Quint, W.; Linde, A. European panels for quality control of nucleic acid amplification of herpes simplex virus (HSV). 5th Annual Meeting of the European Society for Clinical Virology; Lathi, Finland, 2001. An international external quality assessment of nucleic acid amplification of herpes simplex virus. J. Clin. virol. in press.
330. Arens, M.: Methods for subtyping and molecular comparison of human viral genomes. Clin. Microbiol Rev. 1999, 12, 612–626.
331. Cunningham, P.H.; Smith, D.G.; Satchell, C.; Cooper, D.A.; Brew, B. Evidence for independent development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid. AIDS. 2000, 14, 1949–1954.
332. Pease, A.C.; Solas, D.; Sullivan, E.J.; Cronin, M.T.; Holmes, C.P.; Fodor, S.P. Light-generated oligonucleotide arrays for rapid DNA sequence analysis. Proc. Natl. Acad. Sci. USA. 1994, 91, 5022–5026.
333. McGlennen, R.C.: Miniaturization technologies for molecular diagnostics. Clin. Chem. 2001, 47, 393–402.
334. Lockhart, D.J.; Winzeler, E.A. Genomics, gene expression and DNA arrays. Nature. 2000, 405, 827–836.
335. Chambers, J.; Angulo, A.; Amaratunga, D.; Guo, H.; Jiang, Y.; Wan, J.S.; Bittner, A.; Frueh, K.; Jackson, M.R.; Peterson, P.A.; Erlander, M.G.; Ghazal, P. DNA microarrays of the complex human cytomegalovirus genome: profiling kinetic class with drug sensitivity of viral gene expression. J. Virol. 1999, 73, 5757–5766.
336. Jenner, R.G.; Alba, M.M.; Boshoff, C.; Kellam, P.: Kaposi’s sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays. J. Virol. 2001, 75, 891–902.
337. Li, J.; Chen, S.; Evans, D.H. Typing and subtyping influenza virus using DNA microarrays and multiplex reverse transcriptase PCR. J. Clin. Microbiol. 2001, 39, 696–704.
338. Wilson, J.W.; Bean, P.; Robins, T.; Graziano, F.; Persing, D.H. Comparative evaluation of three human immunodeficiency virus genotyping systems: the HIV-GenotypR method, the HIV PRT GeneChip assay, and the HIV-1 RT line probe assay. J. Clin. Microbiol. 2000, 38, 3022–3028.
339. Rozenberg, F.; Lebon, P. Analysis of herpes simplex virus type 1 glycoprotein D nucleotide sequence in human herpes simplex encephalitis. J. Neurovirol. 1996, 2, 289–295.
340. Lee, N.Y.; Tang, Y.; Espy, M.J.; Kolbert, C.P.; Rys, P.N.; Mitchell, P.S.; Day, S.P.; Henry, S.L.; Persing, D.H.; Smith, T.F.: Role of genotypic analysis of the thymidine kinase gene of herpes simplex virus for determination of neurovirulence and resistance to acyclovir. J. Clin. Microbiol. 1999, 37, 3171–3174.
341. Wolf, D.G.; Lee, D.J.; Spector, S.A. Detection of human cytomegalovirus mutations associated with ganciclovir resistance in cerebrospinal fluid of AIDS patients with central nervous system disease. Antimicrob. Agents. Chemother. 1995, 39, 2552–2554.
342. Agostini, H.T.; Stoner, G.L.: Amplification of the complete polyomavirus J. C. genome from brain, cerebrospinal fluid and urine using pre-PCR restriction enzyme digestion. J. Neurovirol. 1995, 1, 316–320.
343. Ferrante, P.; Mediati, M.; Caldarelli-Stefano, R.; Losciale, L.; Mancuso, R.; Cagni, A.E.; Maserati, R. Increased frequency of JCV type 2 and of dual infection with JC virus type 1 and 2 in Italian progressive multifocal leukoencephalopathy patients. J. Neurovirol. 2001, 7, 35–42.
344. Ciappi, S.; Azzi, A.; De Santis, R.; Leoncini, F.; Sterrantino, G.; Mazzotta, F.; Mecocci, L. Archetypal and rearranged sequences of human polyomavirus J. C. transcription control region in peripheral blood leukocytes and in cerebrospinal fluid. J. Gen. Virol. 1999, 80, 1017–1023.
345. Vaz, B.; Cinque, P.; Pickhardt, M.; Weber, T. Analysis of the transcriptional control region in progressive multifocal leukoencephalopathy. J. Neurovirol. 2000, 6, 398–409.
346. Pfister, L.A.; Letvin, N.L.; Koralnik, I.J.: JC virus regulatory region tandem repeats in plasma and central nervous system isolates correlate with poor clinical outcome in patients with progressive multifocal leukoencephalopathy. J. Virol. 2001, 75, 5672–5676.
347. Takami, T.; Sonodat, S.; Houjyo, H.; Kawashima, H.; Takei, Y.; Miyajima, T.; Takekuma, K.; Hoshika, A.; Mori, T.; Nakayama, T.: Diagnosis of horizontal enterovirus infections in neonates by nested PCR and direct sequence analysis. J. Hosp. Infect. 2000, 45, 283–287.
348. Byington, C.L.; Taggart, E.W.; Carroll, K.C.; Hillyard, D.R. A polymerase chain reactionbased epidemiologic investigation of the incidence of nonpolio enteroviral infections in febrile and afebrile infants 90 days and younger. Pediatrics. 1999, 103, E27.
349. Kammerer, U.; Kunkel, B.; Korn, K.: Nested PCR for specific detection and rapid identification of human picornaviruses. J. Clin. Microbiol. 1994, 32, 285–291.
350. Leparc-Goffart, I.; Julien, J.; Fuchs, F.; Janatova, I.; Aymard, M.; Kopecka, H. Evidence of presence of poliovirus genomic sequences in cerebrospinal fluid from patients with postpolio syndrome. J. Clin. Microbiol. 1996, 34, 2023–2026.
351. Furione, M.; Guillot, S.; Otelea, D.; Balanant, J.; Candrea, A.; Crainic, R. Polioviruses with natural recombinant genomes isolated from vaccine-associated paralytic poliomyelitis. Virology. 1993, 196, 199–208.
352. Oberste, M.S.; Maher, K.; Kilpatrick, D.R.; Flemister, M.R.; Brown, B.A.; Pallansch, M.A. Typing of human enteroviruses by partial sequencing of VP 1. J. Clin. Microbiol. 1999, 37, 1288–1293.
353. Brown, B.A.; Kilpatrick, D.R.; Oberste, M.S.; Pallansch, M.A. Serotype-specific identification of enterovirus 71 by PCR. J. Clin. Virol. 2000, 2, 107–112.
354. Brown, E.G.; Furesz, J.; Dimock, K.; Yarosh, W.; Contreras, G. Nucleotide sequence analysis of Urabe mumps vaccine strain that caused meningitis in vaccine recipients. Vaccine. 1991, 9, 840–842.
355. Forsey, T.; Mawn, J.A.; Yates, P.J.; Bentley, M.L.; Minor, P.D. Differentiation of vaccine and wild mumps viruses using the polymerase chain reaction and dideoxynucleotide sequencing. J. Gen. Virol. 1990, 71, 987–990.
356. Kreis, S.; Schoub, B.D.: Partial amplification of the measles virus nucleocapsid gene from stored sera and cerebrospinal fluids for molecular epidemiological studies. J. Med. Virol. 1998, 56, 174–177.
357. Katayama, Y.; Shibahara, K.; Kohama, T.; Homma, M.; Hotta, H.: Molecular epidemiology and changing distribution of genotypes of measles virus field strains in Japan. J. Clin. Microbiol, 35, 2651–2653.
358. Venturi, G.; Catucci, M.; Romano, L.; Corsi, P.; Leoncini, F.; Valensin, P.E.; Zazzi, M. Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples. J. Infect. Dis. 2000, 181, 740–745.
359. Steuler, H.; Storch-Hagenlocher, B.; Wildemann, B.: Distinct populations of human immunodeficiency virus type 1 in blood and cerebrospinal fluid. AIDS Res. Hum. Retroviruses. 1992, 8, 53–59.
360. Kuiken, C.L.; Goudsmit, J.; Weiller, G.F.; Armstrong, J.S.; Hartman, S.; Portegies, P.; Dekker, J.; Cornelissen, M.: Differences in human immunodeficiency virus type 1 V3 sequences from patients with and without AIDS dementia complex. J. Gen. Virol. 1995, 76, 175–180.
361. Keys, B.; Karis, J.; Fadeel, B.; Valentin, A.; Norkrans, G.; Hagberg, L.; Chiodi, F. V3 sequences of paired HIV-1 isolates from blood and cerebrospinal fluid cluster according to host and show variation related to the clinical stage of disease. Virology. 1993, 196, 475–483.
362. Power, C.; McArthur, J.C.; Johnson, R.T.; Griffin, D.E.; Glass, J.D.; Perryman, S.; Chesebro, B.: Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences. J. Virol. 1994, 68, 4643–4649.
363. Di Stefano, M.; Gray, F.; Leitner, T.; Chiodi, F. Analysis of ENV V3 sequences from HIV- 1-infected brain indicates restrained virus expression throughout the disease. J. Med. Virol. 1996, 49, 41–48.
364. Martin, M.; Tsai, T.F.; Cropp, B.; Chang, G.J.; Holmes, D.A.; Tseng, J.; Shieh, W.; Zaki, S.R.; Al-Sanouri, I.; Cutrona, A.F.; Ray, G.; Weld, L.H.; Cetron, M.S.: Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases. Lancet. 2001, 358, 98–104.
365. Schinazi, R.F.; Larder, B.A.; Mellors, J.W. Resistance table: mutations in retroviral genes associated with drug resistance. Int. Antiviral. News. 1997, 5, 129–142.
366. Hirsch, M.S.; Brun-Vezinet, F.; D’Aquila, R.T.; Hammer, S.M.; Johnson, V.A.; Kuritzkes, D.R.; Loveday, C.; Mellors, J.W.; Clotet, B.; Conway, B.; Demeter, L.M.; Vella, S.; Jacobsen, D.M.; Richman, D.D. Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society—USA Panel. JAMA. 2000, 283, 2417–2426.
367. Blennow, K.; Fredman, P.; Wallin, A.; Gottfries, C.G.; Frey, H.; Pirttila, T.; Skoog, I.; Wikkelso, C.; Svennerholm, L.: Formulas for the quantitation of intrathecal IgG production. Their validity in the presence of blood-brain barrier damage and their utility in multiple sclerosis. J. Neurol. Sci. 1994, 121, 90–96.
368. Reiber, H.; Lange, P. Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain. Clin. Chem. 1991, 37, 1153–1160.
369. Boucquey, D.; Chalon, M.P.; Sindic, C.J.; Lamy, M.E.; Laterre, C. Herpes simplex virus type 2 meningitis without genital lesions: an immunoblot study. J. Neurol. 1990, 237, 285–289.
370. Pohl-Koppe, A.; Dahm, C.; Elgas, M.; Kuhn, J.E.; Braun, R.W.; ter Meulen, V. The diagnostic significance of the polymerase chain reaction and isoelectric focusing in herpes simplex virus encephalitis. J. Med. Virol. 1992, 36, 147–154.
371. Sindic, C.J.; Monteyne, P.; Laterre, E.C. The intrathecal synthesis of virus-specific oligoclonal IgG in multiple sclerosis. J. Neuroimmunol. 1994, 54, 75–80.
372. Monteyne, P.; Albert, F.; Weissbrich, B.; Zardini, E.; Ciardi, M.; Cleator, G.M.; Sindic, C.J. The detection of intrathecal synthesis of anti-herpes simplex IgG antibodies: comparison between an antigen-mediated immunoblotting technique and antibody index calculations. European Union Concerted Action on Virus Meningitis and Encephalitis. J. Med. Virol. 1997, 53, 324–331.
373. Mathiesen, T.; Fridell, E.; Fredrikson, S.; Linde, A.; Sundqvist, V.A.; Edler, D.; Wahren, B. Combination ELISAs for antiviral antibodies in CSF and serum in patients with neurological symptoms and in healthy controls. J. Virol. Methods. 1988, 19, 169–179.
374. van Loon, A.M.; van der Logt, J.T.; Heessen, F.W.; Postma, B.; Peeters, M.F. Diagnosis of herpes simplex virus encephalitis by detection of virus-specific immunoglobulins A and G in serum and cerebrospinal fluid by using an antibody-capture enzyme-linked immunosorbent assay. J. Clin. Microbiol. 1989, 27, 1983–1987.
375. van Loon, A.M.; van der Logt, J.T.; Heessen, F.W.; Heeren, M.C.; Zoll, J.: Antibody-capture enzyme-linked immunosorbent assays that use enzyme-labelled antigen for detection of virusspecific immunoglobulin M, A and G in patients with varicella or herpes zoster. Epidemiol. Infect. 1992, 108, 165–174.
376. Gunther, G.; Haglund, M.; Lindquist, L.; Skoldenberg, B.; Forsgren, M. Intrathecal IgM, IgA and IgG antibody response in tick-borne encephalitis. Long-term follow-up related to clinical course and outcome. Clin. Diagn. Virol. 1997, 8, 17–29.
377. Plotkin, S.A. Rabies. Clin. Infect. Dis. 2000, 30, 4–12.
378. Jamnback, T.L.; Beaty, B.J.; Hildreth, S.W.; Brown, K.L.; Gundersen, C.B. Capture immunoglobulin M system for rapid diagnosis of La Crosse (California encephalitis) virus infections. J. Clin. Microbiol. 1982, 16, 577–580.
379. Dykers, T.I.; Brown, K.L.; Gundersen, C.B.; Beaty, B.J. Rapid diagnosis of LaCrosse encephalitis: detection of specific immunoglobulin M in cerebrospinal fluid. J. Clin. Microbiol. 1985, 22, 740–744.
380. Tardei, G.; Ruta, S.; Chitu, V.; Rossi, C.; Tsai, T.F.; Cernescu, C.: Evaluation of immunoglobulin M (IgM) and IgG enzyme immunoassays in serologic diagnosis of West Nile virus infection. J. Clin. Microbiol. 2000, 38, 2232–2239.
381. Innis, B.L. Japanese Encephalitis; Chapman & Hall: London: UK, 1995, 147–174.
382. Burke, D.S.; Nisalak, A.; Hoke, C.H., Jr. Field trial of a Japanese encephalitis diagnostic kit. J. Med. Virol. 1986, 18, 41–49.
383. Cuzzubbo, A.J.; Endy, T.P.; Vaughn, D.W.; Solomon, T.; Nisalak, A.; Kalayanarooj, S.; Dung, N.M.; Warrilow, D.; Aaskov, J.; Devine, P.L. Evaluation of a new commercially available immunoglobulin M capture enzyme-linked immunosorbent assay for diagnosis of Japanese encephalitis infections. J. Clin. Microbiol. 1999, 37, 3738–3741.
384. Xu, Y.; Zhaori, G.; Vene, S.; Shen, K.; Zhou, Y.; Magnius, L.O.; Wahren, B.; Linde, A. Viral etiology of acute childhood encephalitis in Beijing diagnosed by analysis of single samples. Pediatr. Infect. Dis. J. 1996, 15, 1018–1024.
385. Kiessling, W.R.; Hall, W.W.; Yung, L.L.; ter Meulen, V. Measles-virus-specific immunoglobulin- M response in subacute sclerosing panencephalitis. Lancet. 1977, 1, 324–327.
386. Gershon, A.; Steinberg, S.; Greenberg, S.; Taber, L. Varicella-zoster-associated encephalitis: detection of specific antibody in cerebrospinal fluid. J. Clin. Microbiol. 1980, 12, 764–767.
387. Casas, I.; Tenorio, A.; De Ory, F.; Lozano, A.; Echevarria, J.M.: Detection of both herpes simplex and varicella-zoster viruses in cerebrospinal fluid from patients with encephalitis. J. Med. Virol. 1996, 50, 82–92.
388. Vandvik, B.; Nilsen, R.E.; Vartdal, F.; Norrby, E. Mumps meningitis: specific and nonspecific antibody responses in the central nervous system. Acta. Neurol. Scand. 1982, 65, 468–487.
389. Conrad, A.J.; Chiang, E.Y.; Andeen, L.E.; Avolio, C.; Walker, S.M.; Baumhefner, R.W.; Mirzayan, R.; Tourtellotte, W.W. Quantitation of intrathecal measles virus IgG antibody synthesis rate: subacute sclerosing panencephalitis and multiple sclerosis. J. Neuroimmunol. 1994, 54, 99–108.
390. Felgenhauer, K.; Reiber, H. The diagnostic significance of antibody specificity indices in multiple sclerosis and herpes virus induced diseases of the nervous system. Clin. Invest. 1992, 70, 28–37.
391. Weber, T.; Beck, R.; Stark, E.; Gerhards, J.; Korn, K.; Haas, J.; Luer, W.; Jahn, G. Comparative analysis of intrathecal antibody synthesis and DNA amplification for the diagnosis of cytomegalovirus infection of the central nervous system in AIDS patients. J. Neurol. 1994, 241, 407–414.
392. Studahl, M.; Ricksten, A.; Sandberg, T.; Elowson, S.; Herner, S.; Sall, C.; Bergstrom, T. Cytomegalovirus infection of the CNS in non-compromised patients. Acta. Neurol. Scand. 1994, 89, 451–457.
393. Weber, T.; Trebst, C.; Frye, S.; Cinque, P.; Vago, L.; Sindic, C.J.; Schulz-Schaeffer, W.J.; Kretzschmar, H.A.; Enzensberger, W.; Hunsmann, G.; Luke, W.: Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy. J. Infect. Dis. 1997, 176, 250–254.
394. Sindic, C.J.; Trebst, C.; Van Antwerpen, M.P.; Frye, S.; Enzensberger, W.; Hunsmann, G.; Luke, W.; Weber, T. Detection of CSF-specific oligocolonal antibodies to recombinant J C virus VP1 in patients with progressive multifocal leukoencephalopathy. J. Neuroimmunol. 1997, 76, 100–104.
395. Antoine, J.C.; Pozetto, B.; Lucht, F.; Michel, D.; Gaudin, O.G.; Rousset, H. Acute adenovirus encephalitis diagnosed by prolonged intrathecal antibody production. Lancet. 1987, 1, 1382.
396. Resnick, L.; diMarzo-Veronese, F.; Schupbach, J.; Tourtellotte, W.W.; Ho, D.D.; Muller, F.; Shapshak, P.; Vogt, M.; Groopman, J.E.; Markham, P.D. Intra-blood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex. N. Engl. J. Med. 1985, 313, 1498–1504.